PST 04102 Disease Control and Prevention-1
PST 04102 Disease Control and Prevention-1
PST 04102Disease
Control and
Prevention
NTA Level 4
Semester 1
Facilitator
Guide
PST 04102 Disease Control and Prevention NTA Level 4 Semester 1 Facilitator Guide
i
December 2016
PST 04102 Disease Control and Prevention NTA Level 4 Semester 1 Facilitator Guide
ii
Copyright © Ministry of Health, Community Development, Gender, Elderly and Children – 2016
PST 04102 Disease Control and Prevention NTA Level 4 Semester 1 Facilitator Guide
iii
Table of Contents
Background v
Acknowledgment vi
Introduction viii
Abbreviations/Acronym xi
Session 1: Concepts of Disease Control and Prevention 1
Session 2: Methods of Controlling Common Air-borne Diseases7
Session 3: Methods of Controlling Diseases Transmitted by Faecal
Contamination 12
Session 4: Methods of Controlling Vector-borne Diseases17
Session 5: Methods of Controlling Disease Transmitted by Animal Bites 22
Session 6: Measures to Improve Hygiene and Sanitation 27
Session 7: Measures for Preventing Water Contamination 32
Session 8: Water Treatment Methods 39
Session 9: Water for Pharmaceutical Use 44
Session 10: Methods for Safe Sewage Disposal 49
Session 11: Health Hazards of Poor Housing and Ventilation 55
Session 12: Air Purification in Pharmaceutical Settings 62
Session 13: Using Antiseptics and Disinfectants 67
Session 14: Introduction to Common Communicable Diseases 75
Session 15: Identification of Patients with Malaria 83
Session 16: Identification of Patients with Common Cold 94
Session 17: Identification of Patients with Tonsillitis 99
Session 18: Identification of Patients with Bronchitis 104
Session 19: Identification of Patients with Pneumonia 109
Session 20: Identification of Patients with Amoebiasis 115
Session 21: Identification of Patients with Typhoid Fever 121
Session 22: Identification of Patients with Food Poisoning 126
Session 23: Identification of Patients with Cholera 133
Session 24: Identification of Patients with Ascariasis 140
Session 25: Identification of Patients with Scabies 147
Session 26: Identification of Patients with Dermatophytes154
Session 27: Identification of Patients with HIV/AIDS 161
Session 28: Identification of Patients with Tuberculosis 172
Session 29: Identification of Patients with Leprosy 182
Session 30: Identification of Patients with Gonorrhoea 188
Session 31: Identification of Patients with Syphilis 193
Session 32: Identification of Patients with Trichomoniasis 200
Session 33: Identification of Patients with Vaginal Candidiasis 206
Session 34: Introduction to Common Non-communicable Diseases 212
Session 35: Identification of Patients with Hypertension 217
Session 36: Identification of Patients with Diabetes223
PST 04102 Disease Control and Prevention NTA Level 4 Semester 1 Facilitator Guide
iv
Session 37: Identification of Patients with Peptic Ulcers 230
Session 38: Identification of Patients with Asthma 236
Session 39: Identification of Patients with Allergic Rhinitis 243
Session 40: Prevention and Control of Contamination in Pharmaceutical
Settings 248
Session 41: Methods for Disposing Pharmaceutical Wastes 255
Session 42: Introduction to Human Nutrition270
Session 43: Managing Patients with Nutritional Deficiency Diseases 278
Session 44: Specialised Food Therapy 291
PST 04102 Disease Control and Prevention NTA Level 4 Semester 1 Facilitator Guide
v
Background
There is currently an ever increasing demand for pharmaceutical personnel in Tanzania.
This is due to expanding investment in public and private pharmaceutical sector. Shortage of
trained pharmaceutical human resource contributes to poor quality of pharmaceutical
services and low access to medicines in the country (GIZ, 2012).
Through Public-Private-Partnership (PPP) the Pharmacy Council (PC) together with
Development Partners (DPs) in Germany and Pharmaceutical Training Institutions (PTIs)
worked together to address the shortage of human resource for pharmacy by designing a
project named “Supporting Training Institutions for Improved Pharmaceutical Services in
Tanzania” in order to improve quality and capacity of PTIs in training, particularly of lower
cadre pharmaceutical personnel.
The Pharmacy Council formed a Steering committee that conducted a stakeholders workshop
from18th - 22ndAugust 2014 in Morogoro to initiate the implementation of the project.
Key activities in the implementation of this project included carrying out situational analysis,
curriculum review and harmonization, development of training manual/facilitators guide,
development of assessment plan, training of trainers and supportive supervision.
After the curricula were reviwed and harmonized, the process of developing standardised
training materials was started in August 2015 through Writer’s Workshop approach.
The approach included two workshops (of two weeks each) for developing draft documents
and a one-week workshop for reviewing, editing and formatting the sessions of the modules.
The goals of writers workshops were to build capacity of tutors in the development of
training materials and to develop high-quality, standardized teaching materials.
The training package for pharmacy cadres includes a facilitator guide, assessment plan and
practicum. There are 12 modules for NTA level 4 making 12 facilitator guides and one
practicum guide.
PST 04102 Disease Control and Prevention NTA Level 4 Semester 1 Facilitator Guide
vi
Acknowledgment
The development of standardized training materials of a competence-based curriculum for
pharmaceutical sciences has been accomplished through involvement of different
stakeholders.
Special thanks go to the Pharmacy Council for spearheading the harmonization of training
materials in the pharmacy after noticing that training institutions in Tanzania were using
different curricula and train their students differently.
I would also like to extend my gratitude to St. Luke Foundation (SLF)/Kilimanjaro School of
Pharmacy –Moshi for their tireless efforts to mobilize funds from development partners.
Particular thanks are due to those who led this important process to its completion, Mrs Stella
M. Mpanda Director, Childbirth Survival Intenational, and Members from the secretariat of
National Council for Technical Education (NACTE) for facilitating the process.
Finally, I very much appreciate the contributions of the tutors and content experts
representing PTIs, hospitals, and other health training institutions. Their participation in
meetings and workshops, and their input in the development of this training
manual/facilitators guide have been invaluable.
Dr. O. Gowele
Director of Human Resources Development
Ministry of Health, Community Development, Gender, Elderly and Children
PST 04102 Disease Control and Prevention NTA Level 4 Semester 1 Facilitator Guide
viii
Introduction
Module Overview
This module content is a guide for tutors of Pharmaceutical schools for training of students.
The session contents are based on sub-enabling outcomes and their related tasks of the
curriculum for Basic Technician Course in Pharmaceutical Sciences. The module sub-
enabling outcomes and their related tasks are as indicated in the in the Basic Technician
Certificate in Pharmaceutical Sciences (NTA Level 4) Curriculum
Target Audience
This module is intended for use primarily by tutors of pharmaceutical schools. The module’s
sessions give guidance on the time, activities and provide information on how to teach the
session. The sessions include different activities which focus on increasing students’
knowledge, skills and attitudes.
PST 04102 Disease Control and Prevention NTA Level 4 Semester 1 Facilitator Guide
ix
Instructions for Use and Facilitators Preparation
Tutors are expected to use the module as a guide to train students in the classroom and
skills laboratory
The contents of the modules are the basis for teaching and learning Disease Control and
Prevention.
Use the session contents as a guide
The tutors are therefore advised to read each session and the relevant handouts and
worksheets as preparation before facilitating the session
Tutors need to prepare all the resources, as indicated in the resource section or any other
item, for an effective teaching and learning process
Plan a schedule (timetable) of the training activities
Facilitators are expected to be innovative to make the teaching and learning process
effective
Read the sessions before facilitation; make sure you understand the contents in order to
clarify points during facilitation
Time allocated is estimated, but you are advised to follow the time as much as possible,
and adjust as needed
Use session activities and exercises suggested in the sessions as a guide
Always involve students in their own learning. When students are involved, they learn
more effectively
Facilitators are encouraged to use real life examples to make learning more realistic
Make use of appropriate reference materials and teaching resources available locally
PST 04102 Disease Control and Prevention NTA Level 4 Semester 1 Facilitator Guide
x
Abbreviations/Acronym
PST 04102 Disease Control and Prevention NTA Level 4 Semester 1 Facilitator Guide
xi
Session 1: Concepts of Disease Control and Prevention
Prerequisites
None
Learning Task
By the end of this session students are expected to be able to:
Define Terms
Explain Common Terms in Disease and Disease Control/Prevention
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Task
35 minutes Presentation Definition of Common Terms in Disease
2
Buzzing and Disease Control
3 05minutes Presentation Key Points
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Communicable diseases
Diseases which can be transmitted from one person to another or from animal to person
o For example, cholera, tuberculosis
Endemic
The constant presence of a disease or infectious agents within a community
Nosocomial
An infection developing in a patient while in a hospital or acquired in a hospital8 but
could show up after discharge
2
An agent capable of infecting man
A source: an infected host or reservoir of infection
A portal of exit from the source
A suitable means of transmission
A portal of entry into a new host
A susceptible host
Agent
Is an organism, mainly a microorganism but including helminthes that is capable of
causing disease
Diseases from animals and products e.g. tetanus, rabies, anthrax, brucellosis
3
Contact (contagious) diseases e.g. scabies, fungal skin infections, leprosy
Sexually transmitted infections e.g. gonorrhea, syphilis, trichomoniasis
Helminthic diseases e.g. ascariasis, hookworm, taeniasis, trichuriasis
Disease Control
Measures designed to prevent further spread of the diseases from the infected persons and
specific treatment to minimize time for transmission and to reduce morbidity and
mortality
Methods for disease control include:
o Preventive measures e.g. isolation, immunization
o Treatment
o Surveillance
4
STEP 3: Key Points (5 minutes)
Diseases may be divided into 2 broad categories which are communicable and non-
communicable diseases.
Principles of disease transmission includes agent, source, means of transmission, portal of
exit, portal of entry and susceptible host
Disease control requires immediate preventive measures, proper treatment and continuous
surveillance to reduce morbidity and mortality
5
References
Cook, G., & Zumla, A. (2003). Manson’s Tropical Diseases. (21st ed.). London:
Saunders Ltd.
Denyer, S. P., Hodges, N. A., Gorman, S. P., & Gilmore BF (2011) (eds.),Hugo& Russell’s
Pharmaceutical Microbiology (8th ed). Oxford: Willey-Blackwell publishing
GoT (2004).National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013).Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
GoT (2013).National Tuberculosis and Leprosy Programme: Manual for the management of
tuberculosis and leprosy (6thed) Dar es Salaam: MOHSW
GoT (2012).National Guidelines for Management of HIV and AIDS. (4thed) Dar es Salaam:
MOHSW/NACP
GoT (2013).National Guidelines for Diagnosis and Treatment of Malaria. Dar es salaam:
MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008).Communicable Diseases. (4thed.).
Nairobi: AMREF.
Tanzania Food and Drugs Authority (2009).Guidelines for safe disposal of unfit medicines
and cosmetic products. Dar es Salaam: MOH
6
Session 2: Methods of Controlling Common Air-borne
Diseases
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Common Airborne Diseases
Describe Methods for Prevention and Control of Airborne Diseases + Principles of
Prevention and Control
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
35 minutes Presentation
2 Common Airborne Diseases
Buzzing
60 minutes Presentation
3 Group Prevention and Controlof Airborne Diseases
Discussion
4 05 minutes Presentation Key points
7
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Airborne diseases are diseases that are caused by pathogens and transmitted through the
air
o People spread the disease through sneezing and coughing (see figure 2.1)
ALLOW few groups to present and the rest to add points not mentioned
9
STEP 5: Evaluation (5 minutes)
What are the common airborne diseases?
What are methods for controlling airborne diseases?
10
References
Cook, G., & Zumla, A. (2003). Manson’s Tropical Diseases. (21st ed). London:
Saunders Ltd.
Denyer, S. P., Hodges, N. A., Gorman, S. P., & Gilmore BF (2011) (eds),Hugo& Russell’s
Pharmaceutical Microbiology (8th ed). Oxford: Willey-Blackwell publishing
GoT (2004).National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013).Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
GoT (2013).National Tuberculosis and Leprosy Programme: Manual for the management of
tuberculosis and leprosy (6thed) Dar es Salaam: MOHSW
GoT (2013).National Guidelines for Diagnosis and Treatment of Malaria. Dar es salaam:
MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008).Communicable Diseases. (4thed).
Nairobi: AMREF.
11
Session 3: Methods of Controlling Diseases Transmitted by
Faecal Contamination
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Diseases Transmitted by Faecal Contamination
Describe Methods for Controlling Diseases Transmitted by Faecal Contamination
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
25 minutes Presentation Diseases Transmitted by Faecal
2
Buzzing Contamination
60minutes Presentation
Methods for Controlling Diseases
3 Group
Transmitted by Faecal Contamination
Discussion
4 10minutes Presentation Key Points
12
SESSION CONTENTS
ASK students to pair and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
ALLOW few groups to present and the rest to add points not mentioned
15
References
Cook, G., & Zumla, A. (2003). Manson’s Tropical Diseases. (21st ed). London:
Saunders Ltd.
Denyer, S. P., Hodges, N. A., Gorman, S. P., & Gilmore BF (2011) (eds),Hugo& Russell’s
Pharmaceutical Microbiology (8th ed). Oxford: Willey-Blackwell publishing
GoT (2004).National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013).Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008).Communicable Diseases. (4thed).
Nairobi: AMREF.
16
Session 4: Methods of Controlling Vector-borne Diseases
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
List Common Vector-borne Diseases
Describe Vectors of Medical Importance
Describe Methods of Vector Control
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
17
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
ALLOW few groups to present and the rest to add points not mentioned
19
Vector is any carrier of disease
A vector is required for the transmission of vector-borne diseases.
Measures that reduce vector population and protect susceptible hosts are used to
control vector-borne diseases
20
References
Cook, G., & Zumla, A. (2003). Manson’s Tropical Diseases. (21st ed). London:
Saunders Ltd.
Denyer, S. P., Hodges, N. A., Gorman, S. P., & Gilmore BF (2011) (eds),Hugo& Russell’s
Pharmaceutical Microbiology (8th ed). Oxford: Willey-Blackwell publishing
GoT (2004).National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013).National Guidelines for Diagnosis and Treatment of Malaria. Dar es salaam:
MOHSW
GoT (2013).Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008).Communicable Diseases. (4thed).
Nairobi: AMREF.
21
Session 5: Methods of Controlling Disease Transmitted by
Animal Bites
Total Session Time: 90 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Common Diseases Transmitted by Animal Bites
Flip charts, marker pens, and masking tape Describe Methods for Controlling Diseases
Transmitted by Animal Bites
Resources Needed:
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
30 minutes Presentation Common Diseases Transmitted by Animal
2
Buzzing Bites
30 minutes Presentation
3 Group Methods for Controlling Rabies
Discussion
4 05 minutes Presentation Key Points
22
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Clinical manifestations
Anxiety
Violent behavior
Seizures
Hallucinations
Depression
Paralysis of the limbs
Spasm of pharyngeal muscles
Fear of water (hydrophobia)
23
STEP 3: Methods for Controlling Rabies (30minutes)
ALLOW few groups to present and the rest to add points not mentioned
CLARIFY
24
Activity: Take Home Assignment (10 minutes)
25
References
Cook, G. Zumla, A. (2003). Manson’s Tropical Diseases. (21st ed). London: Saunders Ltd.
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
Nordberg, E., Kingondu T., Mugambi E., Musyoka L, & Otieno F (2007).Communicable
Diseases(4thed). Nairobi: AMREF
Nordberg, E., Kingondu, T., Mugambi, E., et al. (2008) Communicable Diseases. (4th ed.).
Nairobi: AMREF.
26
Session 6: Measures to Improve Hygiene and Sanitation
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Differentiate Hygiene from Sanitation
Describe the Importance of Sanitation and Hygiene
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
30 minutes Presentation Hygiene and Sanitation
2
Buzzing
60 minutes Presentation
3 Small Group Importance of Sanitation and Hygiene
Discussion
4 10 minutes Presentation Key Points
27
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Hygiene – Things that you do to keep yourself and your surrounding clean to maintain good
health. Few examples of hygiene practices are:
Personal hygiene
Food hygiene
Medical hygiene practices, e.g.
o Sterilization of instruments used in surgical procedures
o Use of protective clothing and barriers, such
as masks, gowns, caps, eyewear and gloves
o Safe disposal of medical waste
o Disinfection of reusable materials such as linen, pads, uniforms
o Hand-washing before and after dispensing of medicines
Sanitation – is promotion of health through prevention of human contact with the hazards
of wastes, treatment and proper disposal of sewage or wastewater.
Few examples of sanitation are:
Management of human faeces
Proper handling of food (Food sanitation)
Environmental sanitation
28
Differences between Sanitation and Hygiene
Sanitation Hygiene
Promotion of healthy living and good health Cumulative group of practices perceived by
by preventing human contact with waste and group of people to be a way towards healthy
other forms of organisms causing diseases. living
Associated with human wastes, Associated with human body
environmental wastes and other forms of
wastes
ALLOW few groups to present and the rest to add points not mentioned
Importance of Sanitation
Prevent variety of harmful or deadly bacteria from infecting people
Increase lifespan and improve of quality of life
Ensure safe living environment particularly in the rural setting
Providing measures to control diseases
Importance of hygiene
Protects people against disease germs that are present in the environment
Promote health to “a state of maximum physical and mental well-being” rather than mere
absence of disease
It promotes professional ethics
30
References
Cook, G., & Zumla, A. (2003). Manson’s Tropical Diseases. (21sted.). London: Saunders
Ltd.
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4thed).
Nairobi: AMREF
Nyamwaya, D. (1994): A Guide to Health Promotion through Water and Sanitation, Nairobi:
AMREF
31
Session 7: Measures for Preventing Water Contamination
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session studentsare expected to be able to:
Describe Sources of Water Supply
Identify Sources of Water Contamination
Describe Measures for Preventing Water Contamination
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
25 minutes Presentation Sources of Water Supply
2
Buzzing
30 minutes Presentation Sources of Water Contamination
3 Small Group
Discussion
30 minutes Presentation Measures for Preventing Water
4 Small Group Contamination
Discussion
5 10 minutes Presentation Key Points
32
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Surface Water
The most common source of water for most people
Located in rivers, lakes, streams, reservoirs, oceans, dams, and rain water and snow when
it falls to the surface
Sea water
Water from the sea contains some salts
o The water is concentrated by evaporation and become too salty for drinking
Ground Water
Water which passes through permeable subsoil to the surface
Ground water can be accessed through:
o Springs
o Wells (shallow well, deep well or Artesian/bore-hole wells)
Shallow well taps water above the first impermeable stratum
Deep wells are those derived from water bearing strata below a least one
impervious stratum
Artesian wells are the result of ground pressure in an aquifer being released
through a natural fault, or a bore-hole, so that water is forced to the surface of the
ground
Agricultural activities
o Farmers use of fertilizers and pesticides
o Food processing wastes, including pathogens
o Excess nutrients added by runoff containing detergents or fertilizers
ALLOW few groups to present and the rest to add points not mentioned
References
37
Basset W.H. (1992). Clay’s Handbook of Environmental Health (16thed). London: Chapman
and Hall.
Nyamwaya, D. (1994): A Guide to Health Promotion through Water and Sanitation, Nairobi:
AMREF
Subi, S. (2008).Environmental Health Hand Book for Clinical Officer Students. Kilosa,
Tanzania.
38
Session 8: Water Treatment Methods
Total Session Time: 60 minutes + 2 hours Assignment
Prerequisites
None
Learning Task
By the end of this session students are expected to be able to:
Explain Water Treatment Methods
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Task
40 minutes Presentation
2 Group Water Treatment Methods
Discussion
3 5 minutes Presentation Key Points
39
SESSION CONTENTS
ALLOW few groups to present and the rest to add points not mentioned
The following are common methods for treating contaminated water (Purification)
Filtration
Disinfection
Boiling
Filtration
Purification through sand reduces the bacterial content of the water by 85% to 90%
The two types of filters commonly used in community water supply are:
o Slow sand filter
o Rapid (Pressure) filter
Slow filter
Requires little operational maintenance skills
Applicable in rural areas
Needs attention regularly because it is liable to become a breeding place for bacteria and
water contamination
Disinfection
It is killing of the organisms causing diseases
o There are different methods used to disinfect water supplies, e.g. chlorination, silver
treatment, ultra-violet radiation
Water Chlorination
It is the final safe guard of the quality of water
o The Chlorine should be applied in the water system in such a way that good mixing of
the chlorine with water is ensured
Boiling
Simplest way to treat a small quantity of water for at least 20 minutes
This will kill the organism and render the water harmless
Boiled water is tasteless but it is a safe rule to follow that all drinking water should be
boiled to disinfect it
41
STEP 8: Assignment (5 minutes)
42
References
Basset W.H. (1992). Clay’s Handbook of Environmental Health (16th ed). London: Chapman
and Hall
Nyamwaya, D. (1994): A Guide to Health Promotion through Water and Sanitation, Nairobi:
AMREF
Subi, S. (2008).Environmental Health Hand Book for Clinical Officer Students. Kilosa,
Tanzania.
43
Session 9: Water for Pharmaceutical Use
Total Session Time: 60 minutes + 2 hours Assignment
Prerequisites
None
Learning Task
By the end of this session students are expected to be able to:
Describe Types of Water for Pharmaceutical Use
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Task
Presentation
Types of Water for Pharmaceutical Use
2 40 minutes Group
Discussion
3 5 minutes Presentation Key Points
44
SESSION CONTENTS
ALLOW few groups to present and the rest to add points not mentioned
Water is a widely used substance, raw material in the production, processing and
formulation of pharmaceutical products
Impurities present in water may contaminate or react with intended product substances,
resulting in hazards to health
Control of the quality of water throughout the production, storage and distribution
processes, including microbiological and chemical quality, is very important
Assurance of quality to meet the acceptable standards of pharmaceutical products is
essential
Microbial contamination in the production of pharmaceutical products can be minimized
by proper designing of the system, periodic sanitization and by taking appropriate
measures to prevent microbial proliferation
Different grades of water quality are required depending on the route of administration of
the pharmaceutical products (Different grades of water can be found in pharmacopoeias
and related documents)
Drinking/Portable water
Portable water is water fleshly drawn from public mains supply
It does not include water from local storage tank which may be heavily contaminated with
microorganisms
Portable water is suitable for preparation of pharmaceutical preparation for internal and
external use
Drinking-water should be supplied under continuous positive pressure in a plumbing
system free of any defects that could lead to contamination of any product
Drinking-water is unmodified except for limited treatment of the water derived from a
natural or stored source e.g. springs, wells, rivers, lakes and the sea
o The condition of the source water will dictate the treatment required to render it safe
for human consumption (drinking)
o Treatment includes desalinization, softening, removal of specific ions, particle
reduction and antimicrobial treatment
It is the responsibility of the pharmaceutical manufacturer to assure that the source water
supplying the purified water (PW) treatment system meets the appropriate drinking-water
requirements
Drinking-water quality is covered by the WHO drinking-water guidelines, standards from
the International Organization for Standardization (ISO) and other regional and national
agencies.
Purified water
This is prepared from suitable portable water by distillation or reverse osmosis system
If allowed to stand it may gain a high content of vegetative organisms
Water for pharmaceutical production must be freshly boiled and cooled before us
47
References
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
Liebsch B., Nyamageni DS., Senya SS., & Steinhausen (1988). Tanzania Pharmaceutical
Handbook.Dar es Salaam: Dar es Salaam University Press
48
Session 10: Methods for Safe Sewage Disposal
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Define Sewage
Describe the Importance of Safe Sewage Disposal
Describe Methods for Safe Sewage Disposal
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction , Learning Tasks
15 minutes Presentation Definition of Sewage
2
Buzzing
30 minutes Presentation Importance of Safe Sewage Disposal
3
Brain Storming
45 minutes Presentation
5 Small Group Methods for Safe Sewage Disposal
Discussion
6 10 minutes Presentation Key Points
SESSION CONTENTS
49
STEP1: Presentation of Session Title and Learning Tasks (5 minutes)
READ or ASK students to read the learning tasks and clarify
What is sewage?
Sewage is the mixture of liquid, faeces, toilet paper and food wastes produced by people
o The liquid in sewage includes urine and wastewater which comes from the toilet, the
kitchen, bathroom and laundry
o Sewage contains lots of disease-causing germs and parasites
o Sewage is treated to get rid of as much of the solid matter as possible
o The remaining liquid is called effluent
Sewage disposal is the process in which sewage is transported from inhabited areas
to sewage treatment plants
o This is important to prevent people from getting infection caused by microorganisms
found in the sewage
50
Importance of safe sewage disposal
Protects public health from diseases
Prevent water pollution from sewage contaminants
Remove sources of contaminants from the environment to make it safe.
ALLOW few groups to present and the rest to add points not mentioned
There are main two types of sewage disposal systems which are:
On-site systems
Sewage or effluent systems
51
Figure 10.1: Plan view (top) of an on-site sewage disposal system
On-site disposal systems cannot be installed in all situations. For example, they cannot be
installed:
In areas that flood regularly
In areas that have a high water table (that is, where the underground water is close to the
surface)
Where the amount of wastewater to be disposed of is large
Near to drinking water supplies
52
Before disposal, the sewage is treated. This involves holding the sewage in a closed or
open space for a few days to allow fluids and solids to separate and bacterial action to
turn the sewage into safer form
53
References
Basset, W.H. (1992). Clay’s Handbook of Environmental Health (16th ed). London: Chapman
and Hall
Nyamwaya, D. (1994).A Guide to Health Promotion through Water and Sanitation, Nairobi:
AMREF
Wood CH., Vaughan JP., &de Glanville H (1997).Community Health (2nded). Nairobi:
AMREF
54
Session 11: Health Hazards of Poor Housing and
Ventilation
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe health hazards of poor housing
Explain types of ventilation
Explain importance of proper ventilation in various settings
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers Projector
Computer and LCD Projector
Worksheet 11.1 Diseases caused by poor housing
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
55
SESSION CONTENTS
Housing conditions play a crucial role in the control of many diseases, especially in the
transmission of communicable diseases
House can both protect and facilitate diseases
Definition of terms
House – The usual dwelling place of the family
Housing – The enclosed and adjoining open space and all structural components making
up those spaces
Healthful housing – Housing which permits individuals of all ages to conduct usual
household activities without putting excessive burden upon any organ of the body
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Definition of Ventilation
The process of removing polluted, stale, moisture laden, indoor air and replacing it with
fresh outdoor (often dryer) air
Types of Ventilation
Natural ventilation – Natural movement of air entering and leaving openings such as
windows, doors, and roof ventilators as well as through cracks and crevices of buildings
ALLOW few groups to present and the rest to add points not mentioned
Good ventilation provides enough air (oxygen) required for normal physiological function
in the body
Proper ventilation prevents air pollutants from affecting the health of an individual
Good ventilation helps in removing unwanted smells, such as from cooking or pets
Ventilation controls how much moisture is lingering in a house, and helps a house stay
dry
Moisture can cause mold to build up; which in turn can cause various diseases
58
DIVIDE students in groups or individuals
59
References
Nyamwaya, D. (1994): A Guide to Health Promotion through Water and Sanitation, Nairobi:
AMREF
Wood C. H., Vaughan JP., & de Glanville H. (1997). Community Health (2nded).
Nairobi: AMREF
60
Worksheet 11.1 Diseases caused by poor housing
Assignment
Possible Answers
61
Session 12: Air Purification in Pharmaceutical Settings
Prerequisites
None
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Task
85 minutes Presentation Process and Application of Air Purification
2 in Pharmaceutical Settings
Buzzing
SESSION CONTENTS
62
STEP 2: The Process and Application of Air Purification in
Pharmaceutical Settings (85 minutes)
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pair to add on points not mentioned
Definition of Air purification – It is a process of cleansing the air from impurities and
microorganisms
The process of air purification involve different methods
The methods used in the process of air purification are applied in a sterile manufacturing
room to provide sterile condition to perform sterile pharmaceutical production, as
explained below:
Sterilization by radiation
Means energy that is radiated or transmitted in the form of rays or waves/ particles. The
ionizing radiations include Alpha, Beta, Gamma and X-ray. In a sufficient dose, these
radiations are lethal to all cells, including bacterial spores, which are generally more
resistant than vegetative cells
Bacterial species differ in their sensitivity to ionizing radiations and the degree of
resistance varies during the growth cycle
It is used for the commercial sterilization of large amounts of pre-packed single use items
such as plastic syringes and catheters
63
Mechanical ventilation can exacerbate infiltration and/or exfiltration
o Pressure (propulsion) system: Unlike the exhaust system, this forces the air into
a building and therefore control of entering air is possible, the fresh entering air
displaces the used up air. The advantage of this method is that the source of air-
entry can be controlled and its purity thereby ensured. The air can be filtered,
warmed or cooled as required
64
Air purifiers are very important in capturing a greater number of bacterial and virus
particulates. They are used to reduce the concentration of these airborne contaminants
Visit The Hospital Pharmacy Department and prepare a presentation on the methods that
are used for Air Purification in different sections.
65
References
Salvato J.A. (1982). Environmental Engineering and Sanitation (3rded). New York:
John Wiley and Sons
Subi, S. (2008).Environmental Health Hand Book for Clinical Officer Students. Kilosa:
Tanzania
Wood C. H., Vaughan JP., & de Glanville H. (1997). Community Health (2nded).
Nairobi: AMREF
66
Session 13: Using Antiseptics and Disinfectants
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Differentiate Between Antisepsis and Disinfection
Classify Agents Used for Antisepsis and Disinfection
List Characteristics of an Ideal Disinfectant and Antiseptic
Describe Uses of Various Antiseptics and Disinfectants
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
20 minutes Presentation Antisepsis and Disinfection
2
Buzzing
45 minutes Presentation Agents used for Antisepsis and Disinfection
3
Brain storming
20 minutes Presentation Characteristics of an Ideal Disinfectant and
4
Antiseptic
10 minutes Presentation Uses of Various Antiseptics and
5
Disinfectants
6 5 minutes Presentation Key Points
67
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
68
STEP 3: Agents used for Antisepsis and Disinfection (45 minutes)
Antiseptics
Ethanol
Mode of action
Has a bactericidal action against most vegetative organisms at a concentration of 60% and
95%, but is not effective against bacterial spores
Therapeutic uses
Evaporating lotion used for hand and skin cleaning
Surgical treatment for various skin lesions
Prevention of bed sores and diminishing sweating (reduce temperature)
Used as solvent in different pharmaceutical preparations
A concentration of 70% either alone or with chlorohexidine or iodine for disinfection of
skin before surgical procedures
Chlorhexidine
Mode of action
An antiseptic which is effective against a wide range of vegetative gram-positive and
gram-negative bacteria, although it has no activity against acid fast bacteria, bacterial
spores and some viruses
Therapeutic uses
Chlorohexidine is used in disinfectant solutions, creams, gels and lozenges
It is also used in various concentrations for disinfection in the following conditions:
o Chlorhexidine 0.5% in 70% ethanol for the preoperative disinfection of the skin
o Chlorhexidine 0.05% solution in glycerin for urethral irrigation and catheter
lubrication
o Chlorhexidine 0.02% solution for bladder irrigation
o Chlorhexidine 1% cream for use in obstetrics
o Chlorhexidine 0.01% as the diacetate for preservation of eye drops
69
Cetrimide
Mode of action
A quaternary ammonium disinfectant that has bacterial activity against both gram-
positive and gram-negative organisms
Therapeutic uses
Cetrimide 0.5% solution for preoperative skin disinfection
Cetrimide 0.05% to 1% is used for the cleansing of polythene tubing and catheters, but
time of immersion should not exceed 30 minutes
Cetrimide in higher concentrations of 15 to 35 is used in shampoos to remove scales in
seborrhea
Cetrimide 1.5% with chlorhexidine gluconate 0.15% is often used as a general purpose
disinfectant
Povidone Iodine
Mode of action
Acts by inhibiting enzymes essential to microbial metabolism
It kills on contact a broad spectrum of pathogenic bacteria, viruses, fungi, protozoa and
yeasts
Therapeutic uses
Skin antiseptics and germicidal skin cleansers
Disinfectant for wounds, abrasions and insect bites
Medicated spray for wounds
Antidandruff shampoos
Medicated adhesive plasters
Gargles and throat lozenges
Vaginal gels and douches
Disinfectants
Sodium Hypochlorite
A solution 8% to about 18% of chlorine is prepared by absorption of chlorine in sodium
hydroxide solution to give sodium hypochlorite
Mode of action
Sodium hypochlorite solutions release chlorine gas which kills most pathogenic
organisms at neutral pH
Therapeutic uses
Rapid disinfection of hard surfaces
Disinfection of food
Disinfection of dairy equipment and babies’ feeding bottles
o Solutions containing up to 0.05% of available chlorine are suitable for use on skin and
wounds
Glutaral
70
Mode of action
Glutaral is an effective disinfectant against vegetative forms of gram-positive and gram-
negative bacteria
It is also effective against acid-fast bacteria, bacterial spores, some fungi and viruses
Therapeutic uses
A 2% aqueous solution of Glutaral buffered to pH 7.5-8.5 (the ambient pH for activity) is
used for the sterilization of endoscopic instruments, thermometers and rubber or plastic
equipment that cannot be sterilized by heat
Mode of action
Cresol and soap solution is effective against a wide range of organisms, but its activity is
reduced in the presence of organic matter
The bactericidal activity of cresol and soap solution varies with the soap used
Linseed and castor oil soaps give the highest values and oleic acid the lowest
It has further been verified that higher values are obtained with coconut oil
Therapeutic uses
In addition to its use as a general disinfectant in hospitals, cresol and soap solution is
widely used in commercial disinfectants
Because it is clear when diluted with water, its use is an advantage in the sterilization of
surgical instruments, since cleanliness can be identified with speed and ease
Adverse effects
o Cresol and soap solution is irritant and corrosive to the skin and should be handled
carefully
o It is caustic to the skin and is unsuitable for skin and wound disinfection
Antiseptics
Should be safe and non-toxic
Microbial activity should be known
Should have instructions on how to use
Should not have residual effects
Should be cost effective
Should be active against a wide range of microorganisms
Should be stable when in contact with organic matter
Should be effective
Should be easy to procure
71
Disinfectants
Bactericidal or bacterial static
Rapid activity
Non corrosive
Cost effectiveness
Availability
Stable when in contact with organic matter
Active against a wide range of microorganisms
Not damaging to instruments
Easily biodegradable and less corrosive to the sewage system
Less volatile and non toxic when it enters the atmosphere
Note
Before acquiring antiseptics and disinfectants for use, the following are things to note;
Expiry date
Label of container (well labeled with correct generic name of the disinfectant)
Cover should explain the type of agent and not be torn
Instructions on how to dilute (if not followed can damage instruments or equipment)
Cautions of use
Disinfectant
Use to kill microorganisms on inanimate objects
Processing instruments and other items
Non critical items/devices
Decontaminating floors, surfaces, walls, and furniture
72
Disinfectants are substances applied to a non living surface for preventing infection by
destroying pathogenic microorganisms
There are various antiseptics and disinfectants with different strengths used in different
situations in health facilities
73
References
MOHSW. (2004). National Infection Prevention and Control Guidelines for Health Care
Services in Tanzania. Dar es Salaam: MoHSW
MOHSW. (2006). Health Care Waste Management Monitoring Plan. Health Education
Unit. Dar es Salaam: MoHSW
MOHSW. (2006). National Standards and Procedures for Health Care Waste
Management in Tanzania.Dar es Salaam: MOHSW
Wood CH., Vaughan JP., & de Glanville H. (1997).Community Health. (2nd ed). Nairobi:
AMREF
74
Session 14: Introduction to Common Communicable
Diseases
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Define common terms used in communicable diseases
Identify Medical Importance of Communicable Diseases
List Common Groups of Communicable Diseases
Describe Mode of Transmission of Communicable Diseases
Describe the Principles of Prevention and Control of Communicable Diseases
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
10 minutes Common Terms used in Communicable
2 Presentation Diseases
75
SESSION CONTENTS
Communicable diseases: Are those which can be transmitted from one person to another or
from animals to person
Epidemic – a widespread occurrence of a disease in a community at a particular time
that appears as new cases at a rate that substantially exceeds what is ‘expected’, based
on recent experience. Therefore it is the unusual occurrence of a disease in the
community
Pandemic (from Greek pan- all + demos- people): An epidemic that spreads across a
large region (for example a continent), or even worldwide.
Reservoir (of infection): Refers to any human beings, animals, arthropods, plants,
soil or inanimate matter or a combination of these in which an infectious agent
normally lives and multiplies, and on which it primarily depends for survival and
reproduction in such a manner that it can be transmitted to a susceptible host
o A reservoir of infection can also be termed as the natural habitat of the infectious
agent
76
o Disease that man is the only reservoir is called anthroponeses e.g. Measles and
cholera
o Those that involve other animals reservoirs are called zoonoses e.g. plague and
rabies
Portal of exit in the human host: Include the respiratory passages, the alimentary
canal, the opening in the genital urinary system and the skin lesion
Vector-Borne Diseases
Vectors are invertebrate hosts (insects, ticks and snails) which are an essential part of the
life cycle of the disease causative organism
Therefore a vector-borne disease is a disease whose transmission requires a vector (i.e.
part of the life cycle of the causative organism takes place within the vector)
Vectors acquire disease organisms by sucking blood from infected persons or animals and
pass them on by same route
Examples are yellow fever, trypanosomiasis, schistosomiasis and malaria
Helminthic diseases
These are diseases caused by parasitic worms. For example; ascariasis, enterobiasis,
trichuriasis, hookworm, strongyloidiasis, taeniasis and hydatidosis
Airborne diseases
These are diseases caused by pathogens transmitted through air. For example; acute
respiratory infections, meningitis, tuberculosis and leprosy
Zoonotic diseases
These are diseases that can be passed between animals and humans. This can be through
contact with animals or animal products. For example; anthrax, brucellosis, rabies,
hydatidosis and tetanus
78
STEP 5: Mode of Transmission of Communicable Diseases (20 minutes)
Activity: Buzzing (10 minutes)
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
79
Table 1: Principles of communicable diseases control
Level of Prevention
Primary prevention: These refer to prevention of healthy people from becoming infected
and or develop a disease. The measures include:
o Immunization
o Health education
o Promotion of nutrition
o Vector control
o Provision of adequate housing
o Hand washing
Secondary prevention: This refers to detection of people who already have a given
disease at the earliest possible stage in order to stop the disease from developing further
and or prevent complications i.e. early detection and prompt treatment
Tertiary prevention: This refers to prevention of disease disability and death in a patient
who has already developed the disease, and has complications or cannot be cured. It
includes rehabilitation
80
STEP 8: Assignment (10 minutes)
81
References
Cook G., & Zumla, A. (2003). Manson’s Tropical Diseases. (21sted.). London:
Saunders Ltd
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4th
ed.)Nairobi: AMREF
82
Session 15: Identification of Patients with Malaria
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session studentsare expected to be able to:
Describe Causes of Malaria,
Describe Mode of Transmission of Malaria
Describe Major Signs and Symptoms of Malaria
Explain Treatment of Malaria
Explain Prevention and Control of Malaria
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD projector
Handout 15.1; Life cycle of malaria parasite
Handout 15.2; Treatment of uncomplicated malaria
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
83
SESSION CONTENTS
Malaria
An acute infection of the blood caused by protozoa of genus Plasmodium
Malaria is the most common disease in the tropical Africa
84
Figure 15.1 Spread of malaria
85
Life cycle of malaria parasite
Divided into two phases
o Asexual cycle occurring in human
o Sexual or sporogony cycle occurring in female Anopheles (mosquito)
Hypnozoites
o This stage of the parasites only occurs in Plasmodium Ovale and Plasmodium Vivax
o The Hypnozoites mature unpredictably and releases new Merozoites responsible for
recurrent infections up to 18 months after primary infection, even though earlier blood
stages may have been cured
o Without treatment (specific) using primaquine, it is thought that this stage may remain
in the liver for life
Gametocytes
o At unknown stage or time in the RBCs cycle, ‘sexual’ forms develop and are in turn
responsible for the survival and transmission of the parasite
o Male and female gametocytes circulate for a few weeks and are taken up by the
feeding mosquito
86
Sporozoites migrate to the salivary glands ready for delivery with the mosquito’s next
meal
87
Inability to drink or breastfeed
Contra-indications of ALU
Hypersensitivity to either Artemether or Lumefantrine
First trimester in Pregnancy
Artesunate Injection
88
Give injectable antiMalarial for minimum of 24 hours even if the patient can tolerate oral
medication earlier before 24 hours, and thereafter, complete treatment by giving a
complete course of Artemether-Lumefantrine
Available formulations are: 30mg, 60mg and 120mg of Artesunate for injection.
The recommended formulation for public sector is 60mg
Injectable Quinine
Injectable Quinine is the alternative treatment for severe Malaria. Formulated as Injection
600mg in 2mls
Indications
o Acceptable alternative choice for treatment of severe Malaria
o Medicine of choice for treatment of severe Malaria in first trimester of pregnancy
Contraindications
o Hypersensitivity to quinine
o Optic neuritis
o Myasthenia gravis
Adverse effects
o Cinconism (Tinnitus, Vertigo and Dizziness)
o Hypotension
o Hypoglycaemia
o Injection site abscess
Administration
o Quinine dihydrochloride injection 10mg/kg is given by intravenous infusion Where
Diluted in 10 ml/kg. body weight of 5% dextrose or dextrose – saline
Infused over 4 hours and repeated every 8 hours.
Nine doses then continue with ALU
STEP 6: Prevention and Control of Malaria (20 minutes)
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
89
o This is done by prompt diagnosis and appropriate treatment of infected individuals
o Controlling the vector population by:
Killing adult mosquito with insecticides
Killing larvae with larvicides
Prevention of breeding by environmental sanitation
Using pre intermittent preventive treatment in pregnancy
Use of insecticides treated nets (ITN)
Use of chemoprophylaxis for example Mefloquine, Proguanil Hydrochloride and
Doxycycline
90
References
Cook, G. & Zumla, A. (2003). Manson’s Tropical Diseases. (21st ed.). London: Saunders Ltd
Denyer, S. P., Hodges, N. A., & Gorman, S. P (2011) (Ed).Hugo & Russell’s Pharmaceutical
Microbiology (8thed). Oxford: Willey-Blackwell publishing
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) National Guidelines for Diagnosis and Treatment of Malaria. Dar es salaam:
MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed).
Dar es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF
91
Handout 15.1 Life Cycle of Malaria Parasite
92
Handout 15.2 Dosage Schedule for Artemether-Lumefantrine
93
Session 16: Identification of Patients with Common Cold
Total Session Time: 60 minutes + 1 hour Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Cause of Common Cold,
Describe Mode of Transmission of Common Cold
Describe Major Signs and Symptoms of Common Cold
Explain Treatment of Common Cold
Explain Prevention and Control of Common Cold
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
10 minutes Presentation Causes of Common Cold
2
Buzzing
3 5 minutes Presentation Mode of Transmission of Common Cold
94
SESSION CONTENTS
An introduction to URTI
Respiratory tract infection: A term used to describe infection of all the parts of the body
that are involved in helping a person to breathe
Upper Respiratory Tract include the nose, sinuses, pharynx and trachea
Respiratory tract infection can be divided into:
o Upper respiratory tract infection
o Lower respiratory tract infection
Common upper respiratory tract infections (URTIs) include:
o Common cold
o Sore throat - usually due to an infection of the pharynx (pharyngitis)
o Tonsillitis - infection of the tonsils
o Sinusitis - infection of the sinuses
o Laryngitis - infection of the larynx
95
Sore throat
Cough
97
References
Cook, G., & Zumla, A. (2003). Manson’s Tropical Diseases. (21sted.). London: Saunders Ltd
Denyer, S. P., Hodges, N. A., Gorman, S. P., & Gilmore BF (2011) (Eds.).Hugo & Russell’s
Pharmaceutical Microbiology (8thed). Oxford: Willey-Blackwell Publishing
Eshuis J., & Manschot, P (1992). Communicable Diseases,(1st ed). Nairobi: AMREF
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4 ed). Dar
es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4th ed.).
Nairobi: AMREF
98
Session 17: Identification of Patients with Tonsillitis
Total Session Time: 60 minutes + 1 hour Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Causes of Tonsillitis
Describe Mode of tansmission of Tonsillitis
Describe Major Signs and Symptoms of Tonsillitis
Explain Treatment of Tonsillitis
Explain Prevention and Control of Tonsillitis
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
99
SESSION CONTENTS
Tonsillitis
At the back of throat, two masses of tissue called tonsils act as filters, trapping germs that
could otherwise enter the airways and cause infection. They also produce antibodies to fight
infection. But sometimes the tonsils themselves become infected, they swell and become
inflamed, a condition known as tonsillitis
Causes
Streptococcal bacteria
Viruses can also cause acute tonsillitis
100
Sore throat and difficult in swallowing
Signs of inflammation e.g. redness of tonsils and white spots
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
101
STEP 7: Evaluation (5 minutes)
What are causes of Tonsillitis?
What is the mode of transmission for Tonsillitis?
What are major signs and symptoms of Tonsillitis?
What is the treatment for common Tonsillitis?
What are the prevention and control measures of Tonsillitis?
102
References
Denyer, S. P. Hodges, N. A. & Gorman, S. P (2011) Ed. Hugo & Russell’s Pharmaceutical
Microbiology (8thed). Oxford: Willey-Blackwel publishing
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF
103
Session 18: Identification of Patients with Bronchitis
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Cause(s) of Bronchitis
Describe Mode of Transmission of Bronchitis
Describe Major Signs and Symptoms of Bronchitis
Explain Treatment of Bronchitis
Explain Prevention and Control of Bronchitis
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
05 minutes Cause(s) of Bronchitis
2 Presentation
104
SESSION CONTENTS
Lower respiratory tract infections include infectious processes of the lungs and bronchi,
for example, Pneumonia and Bronchitis
Bronchitis
Bronchitis refers to an inflammatory condition of the large elements of the trachea-
bronchial tree that is usually associated with a generalized respiratory infection
The disease entity is frequently classified as either acute or chronic
Common condition often caused by viral infections of upper respiratory with secondary
bacterial infection
Common in children with infectious fever e.g. measles, influenza and whooping cough
It is also common in smokers, the elderly and people with chronic chest disorders
Causes
Bacteria: Mycoplasma pneumonia, streptococcal bacteria, haemophillus influenza
Viruses: The common cold viruses, rhinovirus, coronavirus, influenza virus, adenovirus,
and respiratory syncytial virus, account for the majority of cases
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
105
Cough
o Cough is the hallmark of acute bronchitis
o Frequently, the cough is initially non-productive but progresses, yielding
mucopurulent sputum
Fever with malaise, headache and loss of appetite
Dyspnea
Crepitation in the lungs
Wheezing
The patient typically has nonspecific complaints such as malaise and headache, coryza,
and sore throat
Bed rest and mild analgesic-antipyretic therapy are often helpful in relieving the
associated lethargy, malaise, and fever
Bronchitis is primarily a self-limiting illness and rarely a cause of death
Patients should be encouraged to drink fluids to prevent dehydration and possibly
decrease the viscosity of respiratory secretions
Non-steroidal anti-inflammatory drugs such as aspirin or acetaminophen or ibuprofen is
administered every 4 to 6 hours
o In children, aspirin should be avoided and acetaminophen used as the preferred agent
because of the possible association between aspirin use and the development of
Reye’s syndrome
Persistent, mild cough, may be treated with dextromethorphan;
o more severe coughs may require intermittent codeine or other similar agents
When possible, antibiotic therapy is directed toward anticipated respiratory pathogen(s)
for example penicillin
106
STEP 6: Prevention and Control of Bronchitis (30 minutes)
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
References
107
Cook, G.& Zumla, A. (2003). Manson’s Tropical Diseases. (21sted.). London:
Saunders Ltd.
Denyer, S. P. Hodges, N. A.& Gorman, S. P (2011) Ed. Hugo & Russell’s Pharmaceutical
Microbiology (8thed). Oxford: Willey-Blackwell publishing
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
Nordberg, E., Kingondu, T.,& Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF
108
Session 19: Identification of Patients with Pneumonia
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe cause of pneumonia,
Describe Mode of Transmission of Pneumonia
Describe Major Signs and Symptoms of Pneumonia
Explain Treatment of Pneumonia
Explain Prevention and Control of Pneumonia
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
109
SESSION CONTENTS
Pneumonia
Inflammatory condition of the lung caused by infection
Causes
Virus
Bacteria: Pneumococci, Streptococci, Staphylococci, Klebsiellae species and
Haemophillus influenzae
Airborne from upper respiratory tract infection, especially influenza in the elderly,
HIV/AIDS, immunocompromised and measles and whooping cough in children. These
infections cause damage to the epithelium of the lungs and so clear the way for bacterial
superinfection
Transmission is by droplet spread, direct oral contact or indirectly through freshly
infected articles
110
STEP 4: Signs and Symptoms of Pneumonia (10minutes)
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
111
STEP 6: Prevention and Control of Pneumonia (55 minutes)
ALLOW few groups to present and the rest to add points not mentioned
Control measures of lower respiratory tract infections are based on general principles
governing control of airborne diseases
Immunisation to prevent diseases complicated by pneumonia such as measles and
whooping cough is important
Mortality can be reduced by early diagnosis and treatment especially in children and
elderly
Prompt adequate therapy started.
112
STEP 9: Assignment (5 minutes)
113
References
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed).
Dar es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF
114
Session 20: Identification of Patients with Amoebiasis
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Causeof Amoebiasis,
Describe Mode of Transmission of Amoebiasis
Describe Major Signs and Symptoms of Amoebiasis
Explain Treatment of Amoebiasis
Explain Prevention and Control of Amoebiasis
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
115
SESSION CONTENTS
Amoebiasis:
o An infection caused by the amoeba Entamoeba histolytica which is a single-celled
organism
o E. histolytica is often found in food or water contaminated with human faeces.
The main reservoir of E. histolytica is man
A pathogenic intestinal amoeba is spread between humans by its cysts, characterized by
diarrhoea
This infection can be fatal in infant and to older people with low resistance
116
STEP 4: Signs and Symptoms of Amoebiasis (20 minutes)
Infection with amoebae in most cases is asymptomatic
The presenting features may be gradual, severe or fulminating, and include:
o Gradual onset colitis
o Severe acute amoebic dysentery
117
STEP 6: Prevention and Control of Amoebiasis (50 minutes)
ALLOW few groups to present and the rest to add points not mentioned
119
References
Cook, G. Zumla, A. (2003). Manson’s Tropical Diseases. (21sted.). London:
Saunders Ltd
Eshuis ,J, & Manschot, P. (1992). Communicable diseases,(1st ed). Nairobi: AMREF
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed).
Dar es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4th ed.).
Nairobi: AMREF.
120
Session 21: Identification of Patients with Typhoid Fever
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Cause of Typhoid Fever
Describe Mode of Transmission of Typhoid Fever
Describe Major Signs and Symptoms of Common Typhoid Fever
Explain Treatment of Common Typhoid Fever
Explain Prevention and Control of Typhoid Fever
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
121
SESSION CONTENTS
Typhoid fever is a systemic infectious disease, caused by bacteria Salmonella typhi and
Salmonella paratyphi
Mode of transmission
The organisms that are responsible for infection are transmitted through foods or water
contaminated with faeces or urine of a patient or carrier
It is more common in areas where there is insufficient water for washing hands
Typhoid is an exclusively human disease
It is transmitted through the ingestion of food or drink contaminated by the faeces or
urine of infected people
A person may become an asymptomatic carrier of typhoid fever, suffering no symptoms,
but capable of infecting others
Alternatively
Chloramphenicol
o Contraindication: Third trimester of pregnancy
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
123
Safe water, supply and food hygiene will prevent the population from infection
STEP 8: Evaluation (10 minutes)
What is the cause of typhoid fever?
What is the mode of transmission of typhoid fever?
What are signs and symptoms of typhoid fever?
What is the treatment of typhoid fever?
How is typhoid fever prevented?
124
References
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed).
Dar es Salaam: MOHSW
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4th ed.).
Nairobi: AMREF
125
Session 22: Identification of Patients with Food Poisoning
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Cause of Food Poisoning
Describe Mode of Transmission of Food Poisoning
Describe Major Signs and Symptoms of Food Poisoning
Explain Treatment of Food Poisoning
Explain Prevention and Control of Food Poisoning
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
15 minutes Presentation Cause of Food Poisoning
2
Buzzing
15 minutes Presentation Mode of Transmission of Food Poisoning
3
Brainstorming
15 minutes Presentation Major Signs and Symptoms of Food
4 Poisoning
126
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Definition
Food poisoning is an acute intestinal disease acquired by consumption of contaminated food
or water
Causes
Food poisoning can be divided into two categories:
Chemical (heavy metals, fluoride and others)
Infectious: Toxins produced by microorganism present in natural food or bacteria
contaminating food or water
o Infectious agents include viruses, bacteria, and parasites
o Toxic agents include poisonous mushrooms, improperly prepared exotic foods
Bacteria
Bacteria can cause food poisoning in two different ways
o Some bacteria infect the intestines, causing inflammation and difficulty absorbing
nutrients and water, leading to diarrhoea
o Other bacteria produce chemicals in foods (known as toxins) that are poisonous to the
human digestive system
When eaten, these bacterial toxins can lead to nausea, vomiting, kidney failure,
and even death
The common bacteria causing food poisoning are:
Salmonellae,
Campylobacter,
Staphylococcus aureus
Escherichia coli
127
Clostridium botulinum
Vibrio cholerae
Pesticides
In food and naturally toxic substances like poisonous mushrooms or reef fish
Viruses
These viruses include:
o Noroviruses
o Rotavirus
o Enteroviruses
o Hepatitis A
Parasites
They are usually in contaminated or untreated water and cause long-lasting but mild
symptoms
o Examples of parasites which can cause illness are Giardia and Cryptosporidium
Note: Toxic agents are the least common cause of food poisoning
128
STEP 4: Signs and Symptoms of Food Poisoning (15 minutes)
Symptoms of food poisoning depend on the type of contaminant and the amount eaten
The symptoms can develop rapidly, within 30 minutes, or slowly, worsening over days to
weeks
Most of the common signs and symptoms are:
o Nausea,
o Vomiting
o Diarrhoea
o Abdominal cramping
The incubation period is short depending on the cause of food poisoning:
o Staphylococcal food poisoning takes 1 – 6 hours
o Salmonella food poisoning takes 12 – 14 hours
o Anthrax gastrointestinal poisoning take 2 – 5 days
There is acute onset of vomiting and diarrhoea after ingestion of contaminated food
Gastrointestinal anthrax presents with vomiting, abdominal pain, haematemesis, bloody
diarrhoea and toxaemia
Staphylococcus aureus: Causes moderate to severe illness with rapid onset of nausea,
severe vomiting, dizziness, and abdominal cramping
Clostridium botulinum (botulism): Causes severe illness affecting the nervous system
o Symptoms start as blurred vision
o The person then develops problems of talking and overall weakness
o Symptoms then progress to difficulty breathing and inability to move arms or legs
o Botulism has the 4 D’s: diplopia (double vision), dysphagia (difficulty swallowing),
dysarthria/dysphonia (difficulty speaking) and diarrhoea
Neurological symptoms suggest insecticides e.g. organophosphorous or mushroom
poisoning and seafood poisoning
129
STEP 6: Prevention and Control of Food Poisoning (40 minutes)
ALLOW few groups to present and the rest to add points not mentioned
130
Activity: Take Home Assignment (10 minutes)
131
References
Burton, B. T. & Foster W. R. (1988) Human Nutrition; A textbook of nutrition in health and
disease (4thed). New York: McGraw-Hill Book Company
Denyer, S. P. Hodges, N. A. & Gorman, S. P (2011) Ed. Hugo & Russell’s Pharmaceutical
Microbiology (8thed). Oxford: Willey-Blackwell publishing
Eshuis, J. & Manschot, P (1992). Communicable diseases, (1st ed). Nairobi: AMREF
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
GoT (2013) National Tuberculosis and Leprosy Programme: Manual for the management of
tuberculosis and leprosy (6thed). Dar es Salaam: MOHSW
GoT (2012) National Guidelines for Management of HIV and AIDS. (4thed) Dar es Salaam:
MOHSW/NACP
GoT (2013) National Guidelines for Diagnosis and Treatment of Malaria. Dar es Salaam:
MOHSW
GoT (2007) National Guidelines for Management of Sexually Transmitted and Reproductive
Tract Infections (1sted). Dar es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF.
Nyamwaya, D. (1994): A Guide to Health Promotion through Water and Sanitation, Nairobi:
AMREF
Tanzania Food and Drugs Authority (2009), Guidelines for safe disposal of unfit medicines
and cosmetic products. Dar es Salaam: MOH
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Cause of Cholera
Describe Mode of Transmission of Cholera
Describe major Signs and Symptoms of Cholera
Explain Treatment of Common Cholera
Explain Prevention and Control of Cholera
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
10 minutes Presentation Causes of Cholera
2
Buzzing
40 minutes Presentation Mode of Transmission of Cholera
3 Small group
Discussion
10 minutes Presentation Major Signs and Symptoms of Cholera
4
Brainstorming
5 10 minutes Presentation Treatment of Cholera
133
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Definition
Cholera is acute diarrheal infection of the intestine caused by vibrio cholerae
The infection is often mild or without symptoms, but sometimes can be severe and fatal
ALLOW few groups to present and the rest to add points not mentioned
Transmission is through faecal –oral route but almost all cholera infections are water-
borne (see figure 1).
o Vibrio cholera can live in water for 2 weeks and prefer salty water
o Vibrio may survive for longer period and multiply in shellfish
134
The reservoir of infection is formed mainly by carriers excrete vibrio in small numbers
posing danger to the community
135
Second stage:
There is collapse from dehydration
The body becomes cold, the skin dry and inelastic
The blood pressure is low and the pulse is rapid and feeble
Urine production stops and the patient may die of shock
Third stage:
Stage of recovery, either spontaneously or with treatment
Diarrhoea decreases
Patient is able to take fluids and general condition improves
Rehydration
Cholera is cured by appropriate and timely rehydration
o Patients of all ages who are strong enough to drink will take a lot of
glucose/electrolyte solution needed for rehydration and maintenance
It is essential to use oral rehydration solution (ORS) or appropriate intravenous (IV)
fluids to replace the necessary electrolytes.
Patients in shock or who are too weak to drink require intravenous fluids until they can
take in oral fluids.
Antimicrobials
Antimicrobial agents have been shown to shorten the period of diarrhoea and the amount
of fluid loss
o Tetracycline or doxycycline are the drugs of choice
o Erythromycin is an effective alternative both in children and adults
o Cotrimoxazole is also another alternative
Strict isolation is not necessary as only vomitus and stool are infectious
Patients are treated on ‘Cholera bed’ (beds with central hole) through which the
continuous stool can pass into a bucket and fluid loss be measured
136
STEP 6: Prevention and Control of Cholera (30minutes)
ALLOW few groups to present and the rest to add points not mentioned
138
References
Cook, G.& Zumla, A. (2003). Manson’s Tropical Diseases. (21sted.). London: Saunders Ltd
Denyer, S. P. Hodges, N. A.& Gorman, S. P (2011) Ed. Hugo & Russell’s Pharmaceutical
Microbiology (8thed). Oxford: Willey-Blackwell Publishing
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4th ed.).
Nairobi: AMREF
Nyamwaya, D. (1994): A Guide to Health Promotion through Water and Sanitation, Nairobi:
AMREF
139
Session 24: Identification of Patients with Ascariasis
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Causes of Ascariasis
Describe Mode of Transmission of Ascariasis
Describe Major Signs and Symptoms of Ascariasis
Explain Treatment of Ascariasis
Explain Prevention and Control of Ascariasis
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
10 minutes Presentation Cause(s) of Ascariasis
2
Buzzing
30 minutes Presentation Mode of Transmission of Ascariasis
3 Small group
Discussion
4 10 minutes Presentation Major Signs and Symptoms of Ascariasis
140
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
ALLOW few groups to present and the rest to add points not mentioned
Common ways of acquiring Ascariasis include failure to adhere to hygienic practices such
as washing hands before food preparation and proper storage of food
Therefore the disease is related to poor sanitation and hygiene
Infection is acquired from ingestion of food contaminated with mature eggs
The usual vehicles are fruits and other raw food
141
Children are more frequently infected and have higher worm burden than adults because
they like putting contaminated objects into their mouths
Heavy infection in children can contribute to under-nutrition
Adults have much lighter infections, although re-infection can occur throughout life
Refer students to Handout 24:1 Life cycle of ascaris lumbricoides for further
reading
142
Activity: Group discussion (30 minutes)
ALLOW few groups to present and the rest to add points not mentioned
143
Activity: Take Home Assignment (10 minutes)
References
144
Cook, G. Zumla, A. (2003). Manson’s Tropical Diseases. (21sted.). London:
Saunders Ltd.
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF
145
Handout 24.1: Life cycle of Ascaris lumbricoides
146
Session 25: Identification of Patients with Scabies
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Cause(s) of Scabies
Describe Mode of Transmission of Scabies
Describe Major Signs and Symptoms of Scabies
Explain Treatment of Scabies
Explain Prevention and Control of Scabies
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
10 minutes Presentation Cause(s) of Scabies
2
Buzzing
3 10 minutes Presentation Mode of Transmission of Scabies
147
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Scabies: A parasitic infection of the skin characterised by an intense itching with typical
distribution caused by the mite Sarcoptes scabies
Prevalence is high in areas with shortage of water
Common in people who do not take bath regularly
Low socio-economic conditions favour the spread of the disease
148
STEP 4: Signs and Symptoms of Scabies (30 minutes)
149
STEP 5: Treatment of Scabies (30 minutes)
The drug of choice is 10% Benzyl benzoate emulsion (BBE)
Administration information
o After the patient has taken a warm bath, the drug is applied over the whole body
except the face
o After 24 hours of first treatment, the patient should bath again and put on clean
clothes
o The drug has no effect on the eggs, therefore repeat BBE after 4 – 7 days to kill larvae
which have hatched after the first treatment
Other drugs which can be used in the absence of BBE include:
o Tetmosol solution or soap
o Permethrin cream 5% (applied to areas of the body from neck downward and washed
off after 8-14 hours)
o Ivermectin 200µg/kg orally and repeated after 2 weeks or Lindane (1%) lotion or
cream
o Antibiotics are used only when there is a secondary infection (preferably Penicillin)
150
STEP 6: Prevention and Control of Scabies (30 minutes)
ALLOW few groups to present and the rest to add points not mentioned
151
STEP 9: Assignment (5 minutes)
152
References
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF
153
Session 26: Identification of Patients with Dermatophytes
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Cause(s) of Dermatophytes
Describe Mode of Transmission of Dermatophytes
Describe Major Signs and Symptoms of Dermatophytes
Explain Treatment of Dermatophytes
Explain Prevention and Control of Dermatophytes
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board and chalk/whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
10 minutes Presentation Cause(s) of Dermatophytes
2
Buzzing
30 minutes Presentation Mode of Transmission of Dermatophytes
3 Small group
discussion
15 minutes Presentation Major Signs and Symptoms of
4 Buzzing Dermatophytes
154
SESSION CONTENTS
Definition
Dermatomycosis is a term applied to fungal infection of the skin and its appendages i.e.
hair and nails
o Different types are identified according to causative organism, site and clinical
appearance
o They are sometimes indicators of immune suppression as occurs in AIDS, cancer,
diabetes and tuberculosis.
Types of dermatomycosis
Tinea capitis (ringworm of the scalp)
Tinea corporis (ringworm of the body)
Tinea pedis (ringworm of the foot or ‘athlete’s foot’)
Tinea unguium (ringworm of the nails)
Tinea versicolor or pityriasis
ALLOW few groups to present and the rest to add points not mentioned
All fungi may be transmitted to humans by direct skin contact from their habitat in the
soil, vegetation, animals or other individuals
155
Genital infection (balanitis and vulvo-vaginitis) may spread during sexual intercourse but
most candida infections are not sexually transmitted
Local conditions on the skin such as moist and hot environment are predisposing factors
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
156
Tinea Capitis
Griseofulvin is the drug of choice, although oral therapy with itraconazole and terbinafine
are effective alternatives.
Oral fluconazole seems to have similar efficacy to Griseofulvin
Give Griseofulvin at a dosage of 250 mg twice a day or 500mg once a day in adults and
20-25mg/kg for children for 6-12 weeks
Whitefield’s ointment applied twice daily for 3 – 6 weeks has also been used in areas
where the above drugs are not available.
Tinea Corporis
This responds well with application of topical antifungal such as Clotrimazole 1% cream,
lotion or solution (use twice daily), and ketoconazole 2% cream (used once daily)
Severe disease and disease in immune compromised patients should be treated with
systemic agents
Tinea Cruris
Topical antifungal treatment should be used (just as in Tinea corporis)
Resistant lesions can be treated with griseofulvin or other systemic agents
Patients should be advised to dry the area completely after bath and not to wear tight
clothing
Tinea Pedis
Topical agents applied for duration of 4 weeks are usually effective
Chronic or extensive disease may require
o Griseofulvin 250 – 500mg twice daily for 6 – 12 weeks, or
o Terbinafine 250 mg daily or itraconazole 200 mg daily
Tinea Unguium
Systemic antifungal are indicated
Terbinafine and itraconazole are more effective than other agent
157
Activity: Group discussion (15 minutes)
ALLOW few groups to present and the rest to add points not mentioned
159
References
Denyer, S. P. Hodges, N. A. & Gorman, S. P (2011) Ed. Hugo & Russell’s Pharmaceutical
Microbiology (8thed). Oxford: Willey-Blackwell Publishing
Eshuis, J. & Manschot, P (1992). Communicable diseases, (1st ed). Nairobi: AMREF
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF
160
Session 27: Identification of Patients with HIV/AIDS
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Causes of HIV/AIDS
Describe Mode of Transmission of HIV/AIDS
Describe Major Signs and Symptoms of HIV/AIDS
Explain Treatment of HIV/AIDS
Explain prevention and control of HIV/AIDS
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
10 minutes Presentation Causes of HIV/AIDS
2
Buzzing
30 minutes Presentation Mode of Transmission of HIV/AIDS
3 Small group
discussion
10 minutes Presentation Major Signs and Symptoms of HIV/AIDS
4
Brainstorming
5 10 minutes Presentation Treatment of HIV/AIDS
161
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
ALLOW few groups to present and the rest to add points not mentioned
162
Vertical transmission:
o During pregnancy
o During delivery
o During breast feeding
Contact with infected blood products
Transfused with infected blood
Injection drug use (IDU) through needle-sharing, needle stick accidents, unsterilized
needles.
The natural history of HIV can be explained in different stages or clinical presentation
163
Acute HIV infection (window period): can present as any acute viral illness
o HIV antibodies take time to be produced and show up on a blood test
o Window period is the period between time of infection and hen initial detection of
HIV antibodies is possible by laboratory tests
o People who test HIV negative must be tested again after 3 months, when antibodies
should have developed
o DNA/RNA testing can be used to diagnose HIV infection before antibodies are
formed
164
Antiretroviral therapy involves the use of a combination of 3 drugs (triple therapy) e.g.
o 2 NRTI + 1 NNRTI, OR
o 2 NRTI + 1 PI, OR
o 3 NRTI’s
ALLOW few groups to present and the rest to add points not mentioned
Development/Empowerment Interventions
Development/empowerment interventions improve general living conditions through:
o Poverty-alleviation and income-generation programmes e.g. MKUKUTA
o Improvements to infrastructure
o Workshops and training to address gender inequality or to empower youth
Health-Services Interventions
Improve health-services issues:
Provider-initiated testing and counseling (PITC) or voluntary counseling and testing
(VCT)
Provision of ART and care of People Living with HIV (PLHIV)
Strengthening management of STIs
Strengthening prevention of mother-to-child-transmission services (PMTCT) and
provision of ART
Strengthening training for health-care providers
Integrating HIV prevention into care and treatment services
Safe medical practices such as use of sterile syringes and needles
Post exposure prophylaxis (PEP) to health workers
165
Management of STIs
All patients should be assessed by clinicians for STIs because:
o STIs share similar risk factors with HIV infection
o STIs increase the risk of HIV acquisition or HIV transmission
o STIs can often be treated and cured
Abstinence
o Encourage delaying sexual activity for young people
Sexual and reproductive health education to young people in and out of school
Faithfulness (have one faithful uninfected partner)
Using condoms correctly and consistently
o Correcting myths and misconceptions about condoms
Screening and effective treatment of asymptomatic cases
Male circumcision
166
References
Cook, G., & Zumla, A. (2003). Manson’s Tropical Diseases. (21st ed.). London:
Saunders Ltd.
Denyer, S. P. Hodges, N. A. & Gorman, S. P (2011) Ed. Hugo & Russell’s Pharmaceutical
Microbiology (8thed). Oxford: Willey-Blackwell publishing
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
GoT (2013) National Tuberculosis and Leprosy Programme: Manual for the management of
tuberculosis and leprosy (6thed) Dar es Salaam: MOHSW
GoT (2012) National Guidelines for Management of HIV and AIDS. (4thed) Dar es Salaam:
MOHSW/NACP
GoT. (2007) National Guidelines for Management of Sexually Transmitted and Reproductive
Tract Infections (1sted). Dar es Salaam: MOHSW
Nordberg, E., Kingondu, T., &Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF
167
Handout 27.1: Life Cycle of HIV
Life cycle of HIV is divided into seven (7) main steps as described below
Attachment of HIV virus through the interaction between viral glycoprotein and CD4
receptors and co-receptors:
o The spikes on HIV virus attach to special areas on the surface of T-cells called
receptors
Integration of pro-viral DNA to host DNA using other components from the T- cell.
o The viral enzyme (integrase) integrates the proviral DNA into the T-cell DNA.
168
Handout 27.2: Life Cycle of HIV
169
Handout 27.3: WHO Clinical Staging of HIV/AIDS in
adults
The WHO Clinical staging system is based on clinical features believed to have
prognostic significance resulting in four stages of disease progression
WHO staging is done where HIV infection is confirmed by HIV antibody or
virological markers
Staging determines eligibility for ART
WHO staging looks at the clinical presentation of the client or patient
WHO clinical staging can be used effectively without access to CD4 or other
laboratory testing
170
o Respiratory
o Gastrointestinal
o Neurological and ocular
o Generalised
171
Session 28: Identification of Patients with Tuberculosis
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Causes of Tuberculosis
Describe mode of Transmission of Tuberculosis
Describe Major Signs and Symptoms of Tuberculosis
Explain Treatment of Tuberculosis
Explain Prevention and Control of Tuberculosis
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
10 minutes Presentation Causes of Tuberculosis
2
Buzzing
30 minutes Presentation Mode of Transmission ofTuberculosis
3 Small group
Discussion
10 minutes Presentation Major signs and Symptoms of Tuberculosis
4
Brainstorming
5 10 minutes Presentation Treatment of Tuberculosis
172
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Definition
Tuberculosis (TB) is a chronic infectious disease caused mainly by mycobacterium
tuberculosis (M. tuberculosis) and occasionally by mycobacterium bovis or
mycobacterium africanum.
Extra-pulmonary (EPTB)
Affects organs other than the lungs
Non-infectious
Accounts for 20% of all cases of TB
The most common types of extra-pulmonary tuberculosis are:
o TB lymphadenitis
o TB of the bones and joints
o TB meningitis
Tuberculosis is on the increase, especially in countries with high prevalence of HIV
Tuberculosis can kill or render the patient disabled for life if untreated or inadequately
treated
173
STEP 3: Mode of Transmission of Tuberculosis (30 minutes)
ALLOW few groups to present and the rest to add points not mentioned
Note: The majority (90%) of people without HIV infected with mycobacterium tuberculosis
do not develop tuberculosis because their immune system is strong enough to prevent the
development of tuberculosis
Loss of weight
174
Night sweats
Fever
The symptoms for extra-pulmonary tuberculosis depend on the organs involved, for example:
Chest pain in Tb pleurisy
Swelling of lymph nodes in Tb lymphadenitis
Pain and swelling of joints in Tb arthritis
Deformity of the spine (Pott’s disease)
Headache, fever, stiffness of the neck and mental confusion in Tb meningitis
There are five essential first-line anti-TB drugs for adults and children in Tanzania, as
recommended by the MOHSW and WHO.
Drugs are formulated in fixed drug combinations (FDCs)
o Isoniazid (H)
o Rifampicin (R)
o Pyrazinamide (Z)
o Ethambutol (E)
o Streptomycin (S)
Continuation phase
There are always bacilli that remain metabolic inactive, hiding in tissue or macrophages
even after the initial phase of treatment
These are called persisters or semi-dormant and they need much longer treatment before
they are killed
Two drugs are used
o Isoniazid
o Rifampicin
The duration for this phase is at least four (4) months to make a total duration of at least
six (6) months to complete treatment
Handout 28.1: Mode of Action, Potency and Recommended dose of Anti-TB drugs
for further reading
ALLOW few groups to present and the rest to add points not mentioned
176
o Emphasis must be placed on those who are sputum smear-positive (open TB) to make
them smear-negative
o All patients with open TB must be put on treatment as early as possible to prevent
them from infecting others
o Early case finding is an important aspect of TB control
Passive case finding – all health care workers should know the early symptoms of
TB and diagnose it whenever patients reports to facilities
Active contact tracing/case finding – community health workers to visit the homes
of all TB cases to look for other cases
Appropriate health education should be given to patients and relatives so that
symptomatic contacts can be brought to the health facility for investigation
Case holding – those who are put on treatment, should be maintained on treatment until
they finish the whole course of treatment
Strengthen the efficiency and reliability of the health services
o Advertise the routine methods of TB treatment in health facility
o Having special day in a week/month where TB patients are seen
The role of BCG immunization
o Provides partial active immunity against TB
Other important measures are:
o TB patients should be advised not to spit anywhere carelessly
o A sputum mug should be provided in which to spit and disposed carefully
o Overcrowding and poor ventilation at homes should be avoided
o Patients should cough into a piece of cloth to reduce distribution of particles b in the
air
o Hand washing after coughing
178
References
Cook, G. Zumla, A. (2003). Manson’s Tropical Diseases. (21st ed.). London:
Saunders Ltd.
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
GoT (2013) National Tuberculosis and Leprosy Programme: Manual for the management of
tuberculosis and leprosy (6thed) Dar es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF
179
Handout 28.1: Mode of Action, Potency and Recommended
dose of Anti-TB drugs
180
Handout 28.2: Adverse Reactions of Anti-TB Drugs
181
Session 29: Identification of Patients with Leprosy
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Cause(S) of Leprosy
Describe Mode of Transmission of Leprosy
Describe Major Signs and Symptoms of Leprosy
Explain Treatment of Leprosy
Explain Prevention and Control of Leprosy
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board and chalk/whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
182
SESSION CONTENTS
Leprosy bacilli are mainly transmitted through infectious droplets that are spread by an
infectious individual through coughing and sneezing
Patients carrying many leprosy bacilli are called multibacillary (MB) patients
o They are the main source of infection
Individuals with few bacilli in their body are called paucibacillary (PB)
o They are not a significant source of infection
Healthy carriers are people carrying the bacilli without developing the disease
o They are not a significant source of infection
Skin contact with leprosy patients not a means of transmitting leprosy infection
Leprosy has a very long incubation period of 3-30 years, with an average of five years
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
One or more pale or reddish, hypo-pigmented patch(es) on the skin with diminished or
loss of sensation
Painless swelling or lumps in the face and/or earlobes
Enlarged and/or tender nerves
Burning sensation of the skin
Numbness or tingling of hands and/or feet
Weakness of eyelids, hands, and/or feet
Painless wounds or burns on the hands and/or feet
The skin lesion can be single or multiple and in many cases less pigmented than the
surrounding skin. Sometimes lesion is reddish or copper-coloured
The skin lesion may show loss of sensation on light touch, a key feature in leprosy
Lesions can present in different ways, but macules (flat), papules (raised) or sometimes
nodules are the most common
Multi Drug Treatment (MDT) is the only adequate chemotherapy that will kill bacilli
MDT is a combination of a minimum of two anti-leprosy drugs, prescribed in the correct
dosage, taken regularly for a period of 6-12 months
Multi bacillary (MB) patients are treated for a period of 12 months
Paucibacillary (PB) patients are treated for 6 months
Treatment of leprosy with only one drug will result in development of drug-resistance
Treatment is given according to WHO recommended MDT regimens based on the
classification of Multibacillary or Paucibacillary
The patient receives a combination of rifampicin, dapsone and clofazimin in case of MB
or rifampicin and dapsone in case of PB
The patient should thus attend the nearest clinic where she/he is registered to collect
blister pack and for clinical assessment.
184
The patient takes the first dose under direct observation of a health worker
In the following 27 days the patient then takes the medicine without being supervised by
the health worker
References
186
Cook, G., & Zumla, A. (2003), Manson’s Tropical Diseases. (21st ed.). London: Saunders
Eshuis, J. & Manschot, P (1992). Communicable diseases, (1st ed). Nairobi: AMREF
GoT (2004).National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
GoT (2013) National Tuberculosis and Leprosy Programme: Manual for the management of
tuberculosis and leprosy (6thed) Dar es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4th ed.).
Nairobi: AMREF
187
Session 30: Identification of Patients with Gonorrhoea
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Causes of Gonorrhoea
Describe Mode of Transmission of Gonorrhoea
Describe Major Signs and Symptoms of Gonorrhoea
Explain Treatment of Gonorrhoea
Explain Prevention and Control of Gonorrhoea
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
15 minutes Presentation Causes of Gonorrhoea
2
Brainstorming
3 15 minutes Presentation Mode of Transmission of Gonorrhoea
188
SESSION CONTENTS
• What is Gonorrhoea?
189
STEP 4: Signs and Symptoms of Gonorrhoea (30 minutes)
ALLOW few groups to present and the rest to add points not mentioned
The signs and symptoms may differ between men to females as follows;
In males
The earliest symptom is irritation at the urinary meatus
o After an incubation period of 2 – 10 days, symptoms of urethritis develop in majority
of infected men
A burning sensation when passing urine
A purulent yellow and profuse discharge soon follow
Dysuria (difficult in passing urine) may be slight or very severe
Severe dysuria is often accompanied by urgency and frequency and occasionally
Terminal haematuria (blood in urine)
In untreated cases, the discharge which was purulent and profuse gradually become
o Scant and less purulent discharges may present only in the mornings
In females
About 50 -80% of infected women have no symptoms
Urethritis and discharge often may go unnoticed
Cervicitis may cause a discharge
Most of symptoms in females are due to complications of gonorrhoea
The risk of infection after a single exposure to an infected partner ranges from 20 to 35%
in male and from 60 to 90% in females
190
o Cefoxitin
o Cefotaxime
o Spectinomycin (Togamycin)
o Azithromycin
o Cotrimoxazole
191
References
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2007) National Guidelines for Management of Sexually Transmitted and Reproductive
Tract Infections (1st ed). Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF
192
Session 31: Identification of Patients with Syphilis
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Causes of Syphilis
Describe Mode of Transmission of Syphilis
Describe Major Signs and Symptoms of Syphilis
Explain Treatment of Syphilis
Explain Prevention and Control of Syphilis
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board and chalk/whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 5 minutes Presentation Introduction, Learning Tasks
193
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
The spirochaete Treponema pallidum enters the body through mucous membranes and
skin.
The route of transmission of syphilis is almost always through sexual contact, although
there are other routes such as:
o Congenital Syphilis via transmission from mother to child in utero.
o Transfusion of unscreened blood.
o A patient with secondary syphilis who has mucosal or cutaneous lesion may transmit
the disease through physical contact.
o Unusual but possible transmission is accidental contact with infective tissue.
194
STEP 4: Signs and Symptoms of Syphilis (40 minutes)
ALLOW few groups to present and the rest to add points not mentioned
Note: Different manifestations occur depending on the stage of the disease; as outlined
below:
Primary Syphilis
Primary syphilis is typically acquired via direct sexual contact with the
infectious lesions of a person with syphilis.
Approximately 10-90 days after the initial exposure (average 21 days), a skin lesion
appears at the point of contact, which is usually the genitalia, but can be anywhere on the
body
o This lesion, called a chancre which is a firm, painless skin ulceration localized at the
point of initial exposure to the spirochete, often on the penis, vagina, rectum or
elsewhere like lips, tongue, breast etc.
The lesion may persist for 4 to 6 weeks and usually heals spontaneously.
Local lymph node swelling can occur.
195
Secondary Syphilis
• Secondary syphilis occurs approximately 1–6 months (commonly 6 to 8 weeks) after the
primary infection.
• There are many different manifestations of secondary disease.
• A patient with syphilis is most contagious when he or she has secondary syphilis.
• There may be a symmetrical reddish pink non-itchy rash on the trunk and extremities.
• This is accompanied with mild constitutional systems, often described as flu-like.
• These rashes tend to be symmetrical can involve the palms of the hands and the soles of
the feet.
• In moist areas of the body such as anus, vulva, perineum, mouth, and axilla the rash
becomes flat, broad, whitish lesions known as condylomata lata.
• All of these lesions are infectious and harbor active treponema organisms.
Tertiary Syphilis
Tertiary syphilis usually occurs 1–10 years after the initial infection, though in some
Cases it can take up to 50 years.
This stage is characterized by the formation of gummas which are soft, tumor-like lesions
of inflammation known as granulomas.
They may appear almost anywhere in the body including the skeleton and brain.
The more severe manifestations include neurosyphilis and cardiovascular syphilis
The incubation period of syphilis varies from 10 days to 10 weeks with average of 3
weeks.
196
STEP 6: Prevention and Control of Syphilis (30 minutes)
ALLOW few groups to present and the rest to add points not mentioned
Abstinence
o Encourage delaying sexual activity for young people
Sexual and reproductive health education to young people in and out of school
Faithfulness (have one faithful uninfected partner)
Using condoms correctly and consistently
o myths and misconceptions about condoms
Screening and effective treatment of asymptomatic cases
Effective treatment of STIs/RTIs
Voluntary counseling and testing (VCT)
Screening of blood for transfusion
All pregnant women should be screened for syphilis routinely to prevent
congenital syphilis
197
STEP 8: Evaluation (5minutes)
What causes Syphilis?
What is the mode of transmission of Syphilis?
What are the signs and symptoms of Syphilis?
What is the treatment of Syphilis?
What are preventive and control measure of Syphilis?
References
198
Cook, G, & Zumla, A. (2003). Manson’s Tropical Diseases. (21st ed.). London: Saunders
Ltd.
Denyer, S. P. Hodges, N. A., & Gorman, S. P (2011) Ed. Hugo & Russell’s Pharmaceutical
Microbiology (8th ed). Oxford: Willey-Blackwell publishing
Eshuis, J, & Manschot, P. (1992). Communicable diseases, (1st ed). Nairobi: AMREF
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2007) National Guidelines for Management of Sexually Transmitted and Reproductive
Tract Infections (1sted). Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF.
199
Session 32: Identification of Patients with Trichomoniasis
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Causes of Trichomoniasis
Describe Mode of Transmission of Trichomoniasis
Describe Major Signs and Symptoms of Trichomoniasis
Explain Treatment of Trichomoniasis
Explain Prevention and Control of Trichomoniasis
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
200
SESSION CONTENTS
Definition
Trichomoniasis: A highly transmissible protozoal infection of the genital tract of males
and females caused by Trichomonas vaginalis
Trichomoniasis is a very common infection of the female genital tract, affecting about
10% of all women
Transmission is by sexual intercourse or by indirect contact through contaminated clothes
and other articles
Susceptibility is general for both male and females but common in females
The parasite survive in acidic environment (pH 4) found in the vagina of adult women
during the reproductive years
The period of communicability spans from months to years if left untreated
No protective immunity occurs in an individual infected with trichomoniasis
ALLOW few groups to present and the rest to add points not mentioned
ALLOW few groups to present and the rest to add points not mentioned
Abstinence
Encourage delaying sexual activity for young people
Sexual and reproductive health education to young people in and out of school
Faithfulness (have one faithful uninfected partner)
Use of condoms correctly and consistently
o Correct myths and misconceptions about condoms
Screening and effective treatment of asymptomatic cases e.g. partners of the patients
Effective treatment of STIs
203
Activity: Take Home Assignment (5 minutes)
References
204
Cook, G.& Zumla, A. (2003). Manson’s Tropical Diseases. (21sted.). London:
Saunders Ltd.
Denyer, S. P. , Hodges, N. A.& Gorman, S. P (2011) Ed. Hugo & Russell’s Pharmaceutical
Microbiology (8thed). Oxford: Willey-Blackwell publishing
GoT (2004): National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
GoT (2007) National Guidelines for Management of Sexually Transmitted and Reproductive
Tract Infections (1sted). Dar es Salaam: MOHSW
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
Nordberg, E., Kingondu, T., Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF. Nordberg, E. (1999): Communicable Diseases, A Manual for Health
Workers in Sub-Saharan Africa, Nairobi: AMREF
205
Session 33: Identification of Patients with Vaginal
Candidiasis
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Cause(S) of Vaginal Candidiasis
Describe Mode of Transmission of Vaginal Candidiasis
Describe Major Signs And Symptoms of Vaginal Candidiasis
Explain Treatment of Vaginal Candidiasis
Explain Prevention and Control of Vaginal Candidiasis
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
10 minutes Presentation Cause(s) of Viginal Candidiasis
2
Buzzing
20 minutes Mode of Transmission of Viginal
3 Presentation Candidiasis
20 minutes Presentation Major Signs and Symptoms of Vaginal
4 Brainstorming Candidiasis
206
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
207
STEP 4: Signs and Symptoms of Vaginal Candidiasis (20 minutes)
Activity: Brainstorming (5 minutes)
208
STEP 6: Prevention and Control of Candidiasis (30 minutes)
Activity: Group discussion (15 minutes)
ALLOW few groups to present and the rest to add points not mentioned
References
210
Cook, G. & Zumla, A. (2003). Manson’s Tropical Diseases. (21sted.). London:
Saunders Ltd.
Denyer, S. P. Hodges, N. A. & Gorman, S. P (2011) Ed. Hugo & Russell’s Pharmaceutical
Microbiology (8thed). Oxford: Willey-Blackwell publishing
GoT (2004) National Infection Prevention and Control (IPC) Guidelines for Healthcare
Workers. Dar es Salaam: MOHSW
Nordberg, E., Kingondu, T., Mugambi, E., et al. (2008) Communicable Diseases. (4thed.).
Nairobi: AMREF.
GoT (2013) Standard Treatment Guidelines & National Essential Medicines List (4thed). Dar
es Salaam: MOHSW
GoT (2012) National Guidelines for Management of HIV and AIDS. (4thed) Dar es Salaam:
MOHSW/NACP
GoT (2007) National Guidelines for Management of Sexually Transmitted and Reproductive
Tract Infections (1sted). Dar es Salaam: MOHSW
211
Session 34: Introduction to Common Non-communicable
Diseases
Total Session Time: 60 minutes + 2 hours Assignment
Prerequisites
None
Learning Task
By the end of this session students are expected to be able to:
Describe Non-communicable Diseases
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board and chalk/whiteboard markers
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Task
10 minutes Presentation Types of Non-communicable Diseases
2
Brainstorming
3 10 minutes Presentation Risk factors for Non-communicable Diseases
20 minutes Presentation
4 Prevention of Non-communicable Diseases
Buzzing
5 05 minutes Presentation Key points
212
SESSION CONTENTS
Non-communicable diseases (NCD) are medical conditions or diseases which are not
infectious and cannot be transferred from person to person
o Diseases last for long periods of time and progress slowly
213
STEP 4: Prevention and Control of Common Non-Communicable Diseases
(20 minutes)
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Early detection and treatment is important to reduce morbidity and mortality for NCD related
disorders
Advise people to stop smoking tobacco to minimize chance of acquiring chronic
respiratory, cardiovascular and other pathological disorders
Encourage balanced diet and regular physical exercise to avoid
being overweight or obesity
Encourage people to stop or reduce alcohol intake
Focus on behavioural change as the core component of all clinical programmes for the
prevention and management of NCDs
Establish centers to improve preventive programmes for NCDs in local areas
214
STEP 7: Assignment (5 minutes)
215
References
Braunwald, E. & Fauci, A.N. (2008) Harrison’s Principles of Internal Medicine (17thed.).
Oxford: McGraw Hill.
Kumar, P.J. & Clark, M. (2006) Textbook of Clinical Medicine. Churchill: Livingstone.
216
Session 35: Identification of Patients with Hypertension
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Causes of Hypertension
Describe Types of Hypertension
Describe Major Signs and Symptoms of Hypertension
Explain Treatment Of Hypertension
Explain Prevention and Control of Hypertension
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
217
SESSION CONTENTS
Hypertension or high blood pressure is a chronic medical condition in which the blood
pressure in the arteries is persistently raised
Blood pressure is expressed by two measurements:
o The systolic pressure occurs when the left ventricle contract
o The diastolic pressure occurs when the left ventricle relaxes before the next
contraction
Normal blood pressure at rest is within the range of 100–140 millimeters
mercury (mmHg) systolic and 60–90 mmHg diastolic.
Hypertension is present if the blood pressure is persistently at or above 140/90 mmHg for
most adults
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
219
STEP 6: Prevention and Control of Hypertension (40 minutes)
ALLOW few groups to present and the rest to add points not mentioned
Lifestyle changes are recommended to lower blood pressure, before starting drug therapy.
o Maintain normal body weight for adults (e.g. Body mass index 20 – 25 kg/m2)
o Reduce dietary sodium intake
o Engage in regular physical activity e.g. Walking
o Limit alcohol consumption
consume a diet rich in fruit and vegetables
Stop smoking and reduce intake of dietary saturated fat and cholesterol
Lifestyle modification may lower blood pressure as much as antihypertensive drug
Patient education
o Hypertension is a lifelong disorder
Long-term commitment to lifestyle modifications and pharmacological therapy is
required.
Repeated in-depth patient education and counselling improve compliance and
reduce cardiovascular risk factors.
220
STEP 9: Assignment (5 minutes)
221
References
222
Session 36: Identification of Patients with Diabetes
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Causes of Diabetes
Describe Types of Diabetes
Describe Major Signs and Symptoms of Diabetes
Explain Treatment of Common Diabetes
Explain Prevention and Control of Diabetes
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board and chalk/whiteboard markers
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
223
SESSION CONTENTS
224
o Risk Factors for Type 2 Diabetes Mellitus
Family history of diabetes (i.e. parent or sibling with type 2 diabetes)
Obesity i.e. body mass index (BMI) >27kg/m2
Age >45 years
History of gestational diabetes mellitus
Hypertension
High density lipoprotein (HDL) cholesterol <0.90 mmol/l (35mg/dl)
In HIV patients, the HAART therapy can increase risk of diabetes
Gestational diabetes, is the third main form and occurs when pregnant women without
a previous history of diabetes develop a high blood sugar level.
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Clinical features of DM depend on the severity of disease and its complications. They
include:
Polyuria
Polydipsia
Polyphagia
Hyperglycaemia
Glycosuria
Keto acidosis
Coma
Weight loss
Fatigue
Weakness
Blurred vision
Frequent superficial infections e.g. vaginitis, fungal skin infections
Slow healing of skin lesions after minor trauma
225
Figure 36.1: Main symptoms of diabetes
226
Type 2 Diabetes Mellitus
There are several classes of anti-diabetic medications available such as:
o Biguanides; e.g. Metformin
o Sulfonylureas,
First generation e.g. Chlorpropamide, Tolbutamide
Second generation e.g. Glipizide, Gliclazide, Glibenclamide, Glyburide
Third generation e.g. Glimepiride, Gliclazide MR (DIAMICRON MR 60)
o Thiazolidinediones e.g Rosiglitazone
ALLOW few groups to present and the rest to add points not mentioned
228
References
Braunwald, E. & Fauci, A.N. (2008).Harrison’s Principles of Internal Medicine (17thed.).
Oxford: McGraw Hill.
229
Session 37: Identification of Patients with Peptic Ulcers
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Causes of Peptic Ulcers
Describe Types of Peptic Ulcers
Describe Major Signs and Symptoms of Peptic Ulcers
Explain Treatment of Common Peptic Ulcers
Explain Prevention and Control of Peptic Ulcers
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board and chalk/whiteboard markers
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
230
SESSION CONTENTS
Definition : An ulcers is a break in the mucosal surface >5 mm in size, with depth to the
submucosa
Common causes include;
o The bacteria, helicobacter pylori
o non-steroidal anti-inflammatory drugs
o tobacco smoking
o Alcohol
o Psychological stress
o Diet: certain foods can cause dyspepsia, but no convincing studies indicate an
association between ulcer formation and a specific diet.
PUD encompasses:
o Gastric ulcers (GU) which is an ulcer in the stomach
o Duodenal ulcers (DU) which is an ulcer in the first part of the small intestines
(duodenum)
Duodenal and gastric ulcers share common features in terms of pathogenesis, diagnosis,
and treatment, but several factors distinguish them from one another.
231
STEP 4: Signs and Symptoms of Peptic Ulcers (30 minutes)
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Signs and symptoms of peptic ulcer can include one or more of the following:
Epigastric pains associated with mealtimes
o pain appears about three hours after taking a meal in duodenal ulcers
Bloating and abdominal fullness
Hematemesis (vomiting of blood); this can occur due to bleeding directly from a gastric
ulcer, or from damage to the esophagus from severe/continuing vomiting.
Melena (tarry, foul-smelling feces due to presence of oxidized iron from hemoglobin);
Nausea, and copious vomiting;
Loss of appetite
Weight loss
Dyspepsia that becomes constant not relieved by food or antacids, radiating to the back
may indicate a penetrating ulcer
232
Bismuth subsalicylate, tetracycline, and metronidazole etc.
Antacids e.g. Magnesium Trisilicate - offer symptomatic relief by neutralizing stomach
acidity
Acid inhibitory agents - decrease the amount of acid in the stomach helping with healing
of ulcers.
o Histamine 2 receptors blockers (H2 blockers) e.g. Ranitidine, fomatidine
o Proton Pump Inhibitors (PPIs)e.g. Omeprazole, Lansoprazole
Prostaglandin analogue (misoprostol) for prevention of NSAID-induced ulceration
ALLOW few groups to present and the rest to add points not mentioned
Personal hygiene - It's not clear how H. pylori spread, but there's some evidence that it could
be transmitted from person to person or through food and water.
o Wash hands with soap and water before handling
o Eat foods properly cooked
Use NSAIDs with caution.
o Avoid taking aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs
o Take medication with meals
Avoid drinking or drink alcohol in small amounts
o Avoid drinking alcohol when taking medication
Don't smoke. Smokers are much more likely to get ulcers
233
STEP 8: Evaluation (5 minutes)
What causes peptic ulcer?
What are the types of peptic ulcers
What are signs and symptoms of peptic ulcers?
What is the treatment of peptic ulcers?
What are preventive measures of peptic ulcers?
234
References
MOHSW (2005).National Formulary. Dar es Salaam: Ministry of Health and Social Welfare.
Swash, M. & Glynn, M. (2007). Hutchison’s Clinical Methods (22nded.). London: Harcourt
Publishers Ltd.
235
Session 38: Identification of Patients with Asthma
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Causes of Asthma
Describe Major Signs and Symptoms of Asthma
Explain Treatment of Asthma
Describe Prevention and Control of Asthma
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board and chalk/whiteboard markers
Handout 38.1: Bronchial Asthma - Precipitating or Aggravating Factors
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
236
SESSION CONTENTS
Causes
The symptoms are caused by constriction of bronchial smooth muscle (bronchospasm),
oedema of bronchial mucous membrane and blockage of the smaller bronchi with plug of
mucous
It can also be triggered by factors like allergens, infections, exercise, tobacco smoke
inhaled chemicals and drugs for example aspirin
High risk jobs such as farming, painting, janitorial work and plastic manufacturing
Generally it can be caused by a complex interaction of environmental and genetic factors
237
STEP 3: Major Signs and Symptoms of Asthma (10 minutes)
Signs and Symptoms of Asthma:
o Wheezing
o Productive cough
o Shortness of breath (dyspnoea)
o Chest tightness
o Increased respiratory rate
o Increased heart rate
o Diaphoresis (excessive sweating)
o Decreased exercise tolerance
Cough and wheeze are common during the night and may disturb sleep
ALLOW few groups to present and the rest to add points not mentioned
238
Patient Education
Should begin at the time of diagnosis and be revisited in every subsequent consultation.
Education involves the patient understanding the nature of asthma, the practical skills
necessary to manage asthma successfully for example using inhaler devices and monitor
the effect of treatment
Patients should appreciate the differences between the reliever medication
(bronchodilator) and the controller medication (anti-inflammatory)
239
STEP 8: Assignment (10 minutes)
240
References
Kumar, P.J. & Clark, M. (2006).Textbook of Clinical Medicine (6thed.). Churchill: Livingstone
241
Handout 38.1: Bronchial Asthma - Precipitating or
Aggravating Factors
242
Session 39: Identification of Patients with Allergic Rhinitis
Total Session Time: 60 minutes + 1 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Causes of Allergic Rhinitis
Describe Mode of Transmission of Allergic Rhinitis
Describe Major Signs and Symptoms of Allergic Rhinitis
Explain Treatment Allergic Rhinitis
Explain Prevention and Control Allergic Rhinitis
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD Projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
243
SESSION CONTENTS
Definition
Allergic rhinitis is inflammation of the nasal membranes characterized by a combination
of the following symptoms:
o Sneezing
o Nasal congestion
o Conjunctival irritation
o Nasal and pharyngeal itching
o Lacrimation (rhinorrhea)
Rhinitis is present if sneezing attacks, nasal discharge or blockage occur for more than an
hour on most days for:
o A limited period of the year (seasonal rhinitis-often called hay fever)
o Throughout the whole year (perennial rhinitis)
244
Symptoms of Allergic Rhinitis
o Sneezing
o Itching (of nose, eyes, ears, and Palate)
o Rhinorrhea
o Postnasal drip
o Congestion
o Anosmia
o Headache
o Ear ache
o Tearing
o Red eyes
o Eye swelling
o Fatigue
o Drowsiness
o Malaise
Corticosteroids
Nasal corticosteroid sprays are the most effective treatment for allergic rhinitis.
They work best when used for long term, but they can also be helpful when used for
shorter periods
Decongestants
Decongestants may also be helpful in reducing symptoms such as nasal congestion.
Nasal spray decongestants should not be used for more than 3 days.
245
STEP 6: Key Points (5 minutes)
Allergic rhinitis is inflammation of the nasal membranes
Allergic rhinitis is caused by allergens common in childhood, adolescence and early adult
hood
Treatment depends on the type and severity of symptoms, age, and whether
there are other medical conditions (such as asthma)
Prevention involves avoiding all triggering factors of your symptoms
246
References
Braunwald, E. & Fauci, A.N. (2008).Harrison’s Principles of Internal Medicine (17thed)
Oxford: McGraw Hill.
Kumar, P.J. & Clark, M. (2006).Textbook of Clinical Medicine (6th ed.). Churchill:
Livingstone
247
Session 40: Prevention and Control of Contamination in
Pharmaceutical Settings
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Explain Sources of Contamination in Pharmaceutical Settings
Explain The Consequences of Contamination on Pharmaceutical Products
Describe Measures for Preventing and Controlling Contamination in Pharmaceutical
Settings
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board and chalk/whiteboard markers
Computer and LCD
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
248
SESSION CONTENTS
Microbiological contamination
Refers to non- intended or accidental introduction of infectious material like bacteria, yeast,
mould, fungi, virus, prions, protozoa or their toxins and by-products
In manufacture/ compounding
Regardless of whether manufacture takes place in industry or on a smaller scale in the
hospital pharmacy, the microbiological quality of the finished product will be determined
by:
o Formulation components used
o Environment in which they are manufactured
o Manufacturing process itself.
Quality must be built into the product at all stages of the process and not inspected at the
end of manufacture or compounding. The following are sources of contamination:
o Raw materials: particularly water and ingredients
o Processing equipment
o Cleaning equipment: Premises/environment
o Staff
o Packaging
249
In use
Pharmaceutical manufacturers may argue that their responsibility ends with the supply of
a well- preserved product of high microbiological standard in a suitable pack and that the
subsequent use, or abuse, of the product is of little concern to them.
Human sources:
o During normal usage, patients may contaminate their medicine with their own
microbial flora; subsequent use of such products may or may not result in self –
infection.
o Topical products are considered to be most at risk, as the product will probably be
applied by hand, thus introducing contaminants from the resident skin flora of
staphylococci,
o Micrococcus species and diphtheroids but also perhaps transient contaminants, such
as pseudomonas or coliforms, which would normally be removed with effective hand-
washing.
o A further potential source of contamination in hospitals is the nursing staff
responsible for medicament administration.
Environmental sources:
o Small numbers of airborne contaminants may settle in products left open to the
atmosphere.
Equipment sources:
o Patients and nursing staff may use a range of applicators (pads, sponges, brushes and
spatulas) during medicament administration, particularly for topical products
o If reused, these easily become contaminated and may be responsible for perpetuating
contamination between fresh stocks of product, as has indeed been shown in studies
of cosmetic products.
250
STEP 3: Consequences of Contamination on Pharmaceutical Products (20
minutes)
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Initiating infections
o Cross-contamination of medicines contributes to most of the nosocomial infections
occurring in hospitals
o It also accounts for most of the postsurgical infections and deaths occurring in
hospitals.
o Cross-contaminated medicines weaken the relationship between patients and
healthcare givers.
o This occurs mostly in the event of drug resistance and treatment failure, but also
infections due to contaminated medicines make patients lose trust in their health care
givers.
Medicines spoilage
o This occurs by microorganisms chemically decomposing the active
ingredient or the excipients. This may lead to:
The product being under- strength,
Physically or chemically unstable, or possibly
Contaminated with toxic materials.
Financial loss
o Contaminated products have financial implications in terms of:
additional treatment costs
product recalls
possible litigation/ legal action
damage to the reputation of the manufacturer or compounder
251
STEP 4: Measures for Preventing and Controlling Contamination in
Pharmaceutical Settings (50 minutes)
ALLOW few groups to present and the rest to add points not mentioned
Raw materials, particularly water and those ingredients of natural origin, must be of a
high microbiological standard.
Water for pharmaceutical manufacture requires some further treatment, usually by
distillation, reverse osmosis or deionization
Processing and compounding equipment should be subjected to planned preventive
maintenance and should be properly cleaned after use to prevent cross - contamination
between batches
Cleaning equipment should be appropriate for the task in hand and should be thoroughly
cleaned and properly maintained.
o These are responsible for distributing organisms around the pharmacy area.
o For example mops, buckets, cleaning cloths and scrubbing machines if stored wet
they provide a convenient niche for microbial growth.
Manufacture should take place in suitable premises, supplied with filtered air, for which
the environmental requirements vary according to the type of product being made.
Free - living opportunist pathogens, such as pseudomonas aeruginosa, can normally be
found in wet sites, such as drains, sinks and taps.
o This may be minimized by observing good manufacturing practices (GMP), by
installing heating traps in sink U - bends, thus destroying one of the main reservoirs of
contaminants
Patients and nurses use a range of applicators (pads, sponges, brushes, spatulas and
spoons) during medicament administration, particularly for topical and oral products.
These should be made as disposable so as to minimise contamination.
In busy wards:
o Hand - washing between attending to patients may be overlooked and
o Contaminants may subsequently be transferred to medicaments during administration
o Emphasize use of non - touch techniques for medicament administration
252
Staff involved in manufacture or compounding should not only have good health but also
a sound knowledge of the importance of personal and production hygiene.
They should dress appropriately and use protective gears such as boots, coats, caps,
gloves and masks in controlling contamination
The end - products requires suitable packaging which will protect it from contamination
during its shelf- life and is itself free from contamination.
Sacking, cardboard, card liners, corks and paper are unsuitable for packaging
pharmaceuticals, as they are heavily contaminated.
o These have now been replaced by non -biodegradable plastic materials.
o Re-use of packaging materials should be discouraged.
o Effective control method includes the supply of products in individual patient’s packs.
253
References
Senya, S., Mwasha, C.Y.S, Muyinga, A.M, Amir, R.I, & Mauga, E.A.S.K, (2011) Tanzania
Pharmaceutical Handbook. (2nded.). Dar es Salaam: ARU Printing Unit
254
Session 41: Methods for Disposing Pharmaceutical Wastes
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Define Terminologies Applied in Disposal of Pharmaceutical Wastes
Describe Categories of Healthcare Wastes
Describe Principles of Waste Management
Describe Methods for Disposal of Pharmaceutical Wastes
Explain Consequences of Improper Disposal of Pharmaceutical Wastes
Describe Procedure for Safe Disposal of Unfit Medicines as per Tanzania Foods, Drugs
and Cosmetics Act, 2003
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board and chalk/whiteboard markers
Computer and LCD
Handout 41.1: Categories of Health Care Wastes
Handout 41.2: Category of products and their recommended disposal methods
255
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
SESSION CONTENTS
256
STEP1: Presentation of Session Title and Learning Tasks (5 minutes)
READ or ASK students to read the learning tasks and clarify
257
Classification of HCW
Source: WHO. National Health-Care Waste Management Plans in Sub-Saharan Countries. Guidance
Manual (1999).
Refer students to Handout 41.1: Categories of Health Care Wastes for further
reading
Pharmaceutical waste
Pharmacy department stores in each health care facility should be rigorously managed to
reduce the generation of pharmaceutical waste. Especially, stocks of pharmaceuticals
should be inspected periodically and checked for their durability (expiration date). Stock
positions should be recorded on a regular basis.
258
These wastes usually arise at central locations, i.e. in pharmacies and laboratories and
they are also often found at places where the ready-to-use cytotoxic solutions are
prepared.
The precautions taken during the use of cytotoxic pharmaceuticals must also be applied
on their journey outside the respective establishment, as releases of these products can
have adverse environmental impacts. The management of these wastes, in covered and
impermeable containers, must be strictly controlled. Solid containers must be used for
collection. The use of coded containers is recommended. For reasons of occupational
safety, cytotoxic pharmaceutical wastes must be collected separately from pharmaceutical
waste and disposed in a hazardous waste incineration plant.
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Disposal Methods
Landfill
o Involves placing unfit medicines and cosmetic products directly into a land disposal
site without prior treatment.
o The method is used in disposing off solid waste.
o Small quantities of unfit medicines and cosmetic products produced on a daily basis
may be land filled provided that they are dispersed in large quantities of general
waste.
o Cytotoxic, narcotic drugs and cosmetic products containing heavy metals such as
mercury should not be land filled, even in small quantities.
259
Discarding of untreated unfit medicine and cosmetics into such a site is not
recommended except as a last resort. They should preferably be discharged after
immobilization by encapsulation or inertization.
o Discarding in open uncontrolled dump with insufficient isolation from the aquifer or
other watercourses can lead to pollution, with the risk of drinking water
contamination in the worst cases.
o The disposal exercise should be done amid tight security by Police and be supervised
by technical personnel. This method is applicable to solids, semi-solids, powders,
medicines, waste dosage forms and cosmetics.
Engineered landfill
Such landfill has some features to protect from loss of chemicals into the aquifer. Direct
deposit of medicines and cosmetics is second best to discharging immobilized unfit
medicines and cosmetic products into such a landfill.
Landfill for treated unfit medicines and cosmetics (medicines and cosmetics waste
immobilization)
Immobilization of unfit medicine and cosmetics can be done in the following ways:
2. Encapsulation
In this process waste medicines and cosmetics are immobilized in a solid block within a
plastic or steel drum. The drum should be cleaned before using them and they should not
have contained explosive or hazardous materials previously.
The exercise starts by filling the drum to 75% of their capacity with solid and semi-solid
waste medicines and cosmetics. The remaining space is filled by pouring in a medium such as
cement or cement-lime mixture, plastic foam or bituminous sand.
For ease and speed of filling, the drum lids should be cut open and bent back. Once the drums
are filled to 75% capacity, the mixture of lime, cement and water in the proportions 15:15: 5
(by weight) is added and drum filled to capacity.
Steel drum lids should then be bent back and sealed by seam or spot welding. The sealed
drum lids should be placed at the base of a landfill site and covered with fresh municipal
solid waste. The method is applicable to solids waste, semi-solids, powders, and liquids
260
3. Inertization
The method involves removing the packaging materials (inner and outer container). The unfit
medicines and cosmetics are then ground and a mix of water, cement and lime added to form
a homogenous paste. The paste is then transported in liquid state by concrete mixer truck to a
landfill site and decanted into a normal municipal waste. The paste then sets as a solid mass
dispersed within the municipal solid waste.
The main tools required for the operation are a grinder or road roller to crush the
medicines/cosmetics, concrete mixer, cement, lime and water.
Medicines or cosmetics waste, lime, cement and water are mixed in the following ratios by
weight 65%, 15%, 15% and 5% respectively. Water can be added more than the required
amount when need arises to have satisfactory liquid consistency.
4. Sewer
This is a method used whereby waste medicines and cosmetic products in liquid form e.g.
syrups, lotions and intravenous fluids are diluted with water and flushed into a proper
functioning sewerage system/sewers in small quantities over a period of time without causing
serious public health or environmental effect. Fast flowing watercourses may likewise be
used to flush small quantities of well-diluted liquid medicines/cosmetics or antiseptics.
261
7. Burning in open containers
Paper and cardboard packaging materials, if they are not to be recycled, may be burnt.
Polyvinyl Chloride (PVC) plastic however must not be burnt. Unfit medicines and cosmetics
should not be destroyed by burning at low temperatures in open containers, as toxic
pollutants may be released into the air. It is strongly recommended that only very small
quantities of unfit medicines and cosmetics be disposed of in this way.
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
In general, improper disposal of pharmaceutical wastes and unfit medicines and cosmetics
presents a serious threat to public health. Some of the health risks are;
Contamination of drinking water.
Non-biodegradable antibiotics, antineoplastics and disinfectants may kill bacteria
necessary for the treatment of sewage.
Burning medicines and cosmetics at low temperatures or in open containers results in
release of toxic pollutants into the air which should ideally be avoided.
Inefficient and insecure sorting and disposal may allow medicines and cosmetics beyond
their expiry dates to be diverted for resale to the general public.
In the absence of suitable disposal sites, if stored in their original packing there is a risk of
diversion.
262
STEP 7: Procedure for Safe Disposal of Unfit Medicines as per Tanzania
Foods, Drugs and Cosmetics Act, 2003 (10 minutes)
Disposal of unfit medicines and cosmetic products shall involve the following procedures:
1. A Drug Inspector, Health Officer, Environmental Officer and Policeman shall supervise
the transport of consignment from the owner’s premises to the disposal site for destruction
exercise.
2. The destruction exercise shall be supervised by Health Officer, Environmental Officer,
Policeman and Drug Inspector.
3. Unfit medicines and cosmetic products shall be transported in a closed motor vehicle to
avoid pilferage.
4. Supervisors shall wear protective gears such as overalls, gloves, masks, caps and boots
during the exercise.
5. Upon completion of the exercise, a Drug Disposal Form shall be duly filled in and signed
by the supervisors and owner/owner’s representative.
6. Drug Disposal Form shall be sent to TFDA headquarter offices.
7. Once TFDA has received the form, a certificate of destruction of unfit medicines and
cosmetic products shall be prepared and sent to the consignee.
8. Particular care shall be taken while handling anti- cancer drugs, narcotic drugs and
penicillins to avoid associated hazards.
263
STEP 10: Assignment (10 minutes)
264
References
TFDA. (2009). Guidelines for safe disposal of unfit medicines and cosmetic products(1sted).
Dar-es- salaam: MoHSW
265
Handout 41.1: Categories of Health Care Wastes
A. Non-risk HCW: includes all the waste that has not been infected like general office
waste, packaging or left over food. They are similar to normal household or municipal
waste and can be managed by the municipal waste services. Three groups can be
established:
A1. Recyclable waste: It includes paper, cardboard, non-contaminated plastic or
metal, cans or glass that can be recycled if any recycling industry exists in the country.
A2. Biodegradable waste: This category comprises for instance, left over food or
garden waste that can be composted.
A3. Other non-risk waste: all the non-risk waste that do not belong to categories A1
and A2.
B. Biomedical and health-care waste requiring special attention:
B1. Human anatomical waste: This category comprises non-infectious human body
parts, organs and tissues and blood bags. Examples of such wastes: tissue waste,
removed organs, amputated body parts and placentas
B2. Waste sharps: Sharps are all objects and materials that are closely linked with
health-care activities and pose a potential risk of injury and infection due to their
puncture or cut property. For this reason, sharps are considered as one of the most
hazardous waste generated and they must be managed with the utmost care. Examples
of such wastes: all types of needles, broken glassware, ampoules, scalpel blades,
lancets, vials without content
B3. Pharmaceutical waste: This category comprises expired pharmaceuticals or
pharmaceuticals that are unusable for other reasons. They are divided into three
classes:
B3.1 Non-hazardous pharmaceutical waste: This class includes pharmaceuticals
such as chamomile tea or cough syrup that pose no hazard during collection,
intermediate storage and waste management. They are not considered hazardous
wastes and should be managed jointly with municipal waste.
B3.2 Potentially hazardous pharmaceutical waste: This class embraces
pharmaceuticals that pose a potential hazard when used improperly by unauthorized
persons. They are considered as hazardous wastes and their management must take
place in an appropriate waste disposal facility.
B3.3 Hazardous pharmaceutical waste: This comprises heavy metal containing
and unidentifiable pharmaceuticals as well as heavy metal containing disinfectants,
which owing to their composition require special management. They must be
considered as hazardous wastes and their management must take place in an
appropriate waste disposal facility.
B4. Cytotoxic pharmaceutical waste: these can arise by use (administration to
patients), manufacture and preparation of pharmaceuticals with a cytotoxic
(antineoplastic) effect. These chemical substances can be subdivided into six main
groups: alkylated substances, antimetabolites, antibiotics, plant alkaloids, hormones,
and others. A potential health risk to persons who handle cytotoxic pharmaceuticals
266
results above all from the mutagenic, carcinogenic and teratogenic properties of these
substances. Consequently, these wastes pose a hazard, and the measures to be taken
must also include those required by occupational health and safety provisions.
Examples of such wastes: Discernible liquid residues of cytotoxic concentrates, post-
expiration-date cytotoxic pharmaceuticals and materials proven to be visibly
contaminated by cytotoxic pharmaceuticals must be disposed of as cytotoxic
pharmaceutical waste.
B5. Blood and body fluids waste: these are wastes that are not categorized as
infectious waste but are contaminated with human or animal blood, secretions and
excretions. It is warranted to assume that these wastes might be contaminated with
pathogens. Examples of such wastes: Dressing material, swabs, syringes without
needle, infusion equipment without spike, bandages
C. Infectious and highly infectious waste: Special requirements regarding the
management of infectious wastes must be imposed whenever waste is known or –
based on medical experience – expected to be contaminated by causative agents of
diseases and when this contamination gives cause for concern that the disease might
spread. In this category two groups can be considered depending on the degree of
infectiousness that is expected.
C. 1 Infectious waste: This class comprises all biomedical and health-care waste
known or clinically assessed by a medical practitioner or veterinary surgeon to have
the potential of transmitting infectious agents to humans or animals. Waste of this
kind is typically generated in the following places: isolation wards of hospitals;
dialysis wards or centers caring for patients infected with hepatitis viruses (yellow
dialysis); pathology departments; operating theatres; medical practices and
laboratories which mainly treat patients suffering from the diseases specified above. It
includes: Discarded materials or equipment contaminated with blood and its
derivatives, other body fluids or excreta from clinically confirmed infected patients or
animals with hazardous communicable diseases. Contaminated waste from patients
known to have blood-borne infections undergoing haemodialysis (e.g. dialysis
equipment such as tubing and filters, disposable sheets, linen, aprons, gloves or
laboratory coats contaminated with blood); Carcasses as well as litter and animal
faeces from animal test laboratories, if transmission of the above-mentioned diseases
is to be expected. Examples of such wastes: Blood from patients contaminated with
HIV, viral hepatitis, brucellosis, Q fever. Faeces from patients infected with typhoid
fever, enteritis and cholera.
C2. Highly infectious waste: It includes all microbiological cultures in which a
multiplication of pathogens of any kind has occurred. They are generated in institutes
working in the fields of hygiene, microbiology and virology as well as in medical
laboratories, medical practices and similar establishments; laboratories. Examples of
such wastes: Sputum cultures of TB laboratories, contaminated blood clots and
glassware material generated in the medical analysis laboratories, high concentrated
microbiological cultures carried out in medical analysis laboratories.
D. Other hazardous waste: This category of waste is not exclusive to the health-care
sector. They include: gaseous, liquid and solid chemicals, waste with high contents of
heavy metals such as batteries and pressurized containers. Chemical waste consists of
267
discarded chemicals that are generated during disinfecting procedures or cleaning
processes. Not all of them are hazardous but some have toxic, corrosive, flammable,
reactive, explosive, shock sensitive, cyto- or genotoxic properties. Examples of such
wastes: thermometers, blood-pressure gauges, photographic fixing and developing
solutions in X-ray departments, halogenated or non-halogenated solvents, organic and
in-organic chemicals.
E. Radioactive health-care waste: this includes liquids, gases and solids contaminated
with radionuclides whose ionizing radiations have genotoxic effects. The ionizing
radiations of interest in medicine include X and γ-rays as well as α- and β- particles
268
Handout 41.2: Category of products and their recommended
disposal methods
269
Session 42: Introduction to Human Nutrition
Total Session Time: 120 minutes + 2 hours Assignment
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Sources of Different Food Substances
Describe the Composition of each Class of Food (Carbohydrates, Proteins, Fats And Oils,
Vitamins And Minerals)
Define Balanced Diet and Explain its Importance to Human Health
Differentiate Between Fat Soluble and Water Soluble Vitamins
Resources Needed:
Flip charts, marker pens, and masking tape
Black/white board and chalk/whiteboard markers
Computer and LCD projector
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
15 minutes Presentation
2 Sources 0f Different Food Substances
Brainstorming
30 minutes The Composition of each Class 0f Food
Presentation
3 (Carbohydrates, Proteins, Fats and Oils,
Buzzing
Vitamins and Minerals)
40 minutes Presentation Balanced Diet and its Importance to Human
4
Group discussion Health
5 10 minutes Presentation Fat Soluble and Water Soluble Vitamins
270
SESSION CONTENTS
Important terms
Food: is what is eaten or taken into the body by parenteral routes for the purpose of
nourishing the body.
o Foods contain elements called nutrients.
Nutrients: are a variety of chemical substances that, in nature, form part of food.
Nutrients are not the same, they can be quite be different from one another.
Nutrition: is the term standing for the sum of all processes involved in food intake,
assimilation and utilization by the body.
o Food must be available and accessible for consumption
o Body ingests, rearranges, assimilates and utilizes the nutrients consumed in food, for
the purpose of:
Production of energy
Growth
Functioning of organs and systems
Maintenance of life.
Nutritional status: is the result of the body’s nutrient intake and utilization, which may
be good or bad.
Malnutrition: literally means ‘bad nutrition’.
o It means any deviation from normal nutrition.
o Can be either under-nutrition or over-nutrition
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Carbohydrates
These are organic compounds composed of the elements carbon, hydrogen and oxygen.
Carbohydrates provide the main source of energy for the body.
Carbohydrates are classified as:
o Monosaccharide (glucose, fructose, galactose and mannose) are the simplest
carbohydrates.
o For their absorption they can pass through the wall of the alimentary tract without
being changed by digestive enzymes.
o Disaccharides (sucrose, maltose and lactose) and oligosaccharides are also simple
carbohydrates.
These have to be converted by the body into monosaccharides before they can be
absorbed from the alimentary tract.
o Polysaccharides, also called complex carbohydrates, are chemically the most
complicated carbohydrates. Examples are starch, cellulose and glycogen.
These are long chain molecules in which a large number of monosaccharides are
combined.
272
Lipids
These are organic compounds made of the elements carbon, hydrogen and oxygen but in
different proportions and different structural arrangements
Fats and oils provide the body with fuel with very high efficiency
Dietary lipids transport the fat-soluble vitamins (vitamin A, D, E and K)
Absorption of these vitamins does not take place very efficiently in the absence of fat
Lipids that are solid at room temperature (butter, beef fat) are referred to as ‘fats’
Lipids that are in liquid at room temperature are referred to as ‘Oils’
Proteins
Proteins are organic molecules that contain the elements carbon, hydrogen, oxygen and
nitrogen.
Frequently proteins contain sulphur and phosphorus and less frequently, other elements
such as iron, copper and iodine
Nitrogen is the element characteristic of all amino acids and therefore of proteins
Amino acids are classified into two groups:
o Those amino acids which cannot be synthesized in the human body (or synthesized in
inadequate amounts) are termed essential.
o Those which can be synthesized in the body are non-essential amino acids.
Vitamins
Vitamins are organic compounds that perform specific metabolic functions in the body
Most of them are not synthesized in the body, must be provided by dietary sources
Vitamins, unlike carbohydrates, lipids and proteins, do not produce energy.
Vitamins differ widely from one another in terms of chemical structure and biological
functions
Minerals
Minerals are naturally occurring, inorganic, homogenous substances.
These substances are very important to keep the human body in a balancing working
order
Minerals are constituents of the bones, teeth, soft tissue, muscle, blood, and nerve cells.
Minerals act as catalysts for many biological reactions within the body
Mineral classification:
273
o Major minerals includes:
Calcium
Iron
Sodium
Potassium
Magnesium
Phosphorus
Sulfur
o Trace minerals are:
Zinc
Copper
Cobalt
Manganese
Iodine
Chromium
Chloride
Fluoride
Water
This is an essential component of healthy diet. About 60-70% of the total body weight of
a person is water
It is important for transport of nutrients, removal of waste and assists in metabolic
activities of all cells and provides lubrication to moving parts of the body and assist in
regulating body temperature.
Clean and safe water is essential for avoiding water-borne and water related diseases.
Water requirement of a person varies with climate, age, activity, dietetics habits and body
build.
STEP 4: Balanced Diet and Explain its Importance to Human Health (40 minutes)
Activity: Small Group Discussion (10 minutes)
ALLOW few groups to present and the rest to add points not mentioned
Balanced diet
274
A diet that contains the proper proportions of carbohydrates, fats, proteins, vitamins,
minerals, and water necessary to maintain good health.
A balanced meal should contain at least one food from each of the food groups
Balanced diet is important for growth and development
Classification of Vitamins
Fat soluble vitamins are vitamins A, D, E and K.
They are soluble in fats and fat solvents
They are utilized only if there is enough fat in the body.
They have the following general properties:
o Consist of carbon, hydrogen and oxygen
o They are relatively stable during:
Processing,
Preservation
Preparation
o They are stored in the liver and fatty deposits of the body therefore do not have to be consumed on
daily basis
o If consumed in excess can produce toxicity
References
276
Beaton G.H. & Bengoa J.M. (1976).Nutrition in Preventive Medicine. Geneva: WHO
King, S. F & Burgess, A. (2000). Nutrition for Developing Countries.(2nded.) Oxford: Felicity
Oxford University Press.
Tanzania Food and Nutrition Centre.(2009). National Guidelines for Nutrition Care and
Support for People Living with HIV.(2nded.) Dar es Salaam: TFNC
277
Session 43: Managing Patients with Nutritional Deficiency
Diseases
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Describe Common Nutritional Deficiency Diseases
Describe Management of Nutritional Deficiency Diseases
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board and chalk/whiteboard markers
Computer and LCD projector
Handout 43.1
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
50 minutes Presentation
2 Common Nutritional Deficiency Diseases
Buzzing
40minutes Presentation Management of Common Nutritional
3
Group discussion Deficiency Diseases
4 05 minutes Presentation Key Points
278
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Malnutrition
Can occur at any time in the life cycle
When it occurs early in life, irreversible damages can be done to the body and brain
Affects a significant proportion of populations, presenting as macro and or micronutrient
deficiency disorders
Nutrition disorder means any kind of disorder caused by eating too little or too much of
one or more different nutrients
Classification of Malnutrition
Can be classified in different ways but most commonly as under nutrition or over
nutrition
o Under Nutrition occurs when nutrients intake does not meet nutrients needs
o Many nutrients are in high demand due to the constant state of cell lose and later
regeneration in the body
o Over nutrition is prolonged consumption of more nutrients than the body needs
Kwashiorkor
279
Caused by failure to provide an adequate dietary sources of protein to substitute for the
protein
Signs and symptoms includes:
o failure of growth but the child is not severely wasted,
o swollen abdomen,
o hair changes (hair becomes brown, straight and soft)
o skin rashes,
o child becomes inactive, apathetic, irritable and is difficult to feed,
o oedema of lower limbs
Marasmus
Causes: severe loss or chronic waste of fat, muscles and other tissues of the body. The
disease occurs due to shortage of basic nutrition, proteins, vitamins and calories to the
body. It is inadequate energy intake in all forms, including protein.
Signs and Symptoms of Marasmus: remarkable failure of growth, severe muscle wasting
with flaccid, wrinkled skin and bony prominence, the child looks awake and hungry and
displays what is referred to as ‘old person’s face and oedema is absent
Prevention of PEM
The different strategies may include:
o Incorporating nutrition objectives into development of policies and programmes
o Improving household food security
o Protection and promotion of good health
o Improving the quality and safety of foods
o Protect and promote breastfeeding and complementary feeding
o Early treatment of common diseases
o Immunization
o Growth monitoring
o Promoting appropriate diets and healthy lifestyles
Vitamin A Deficiency
It plays important roles in the body including vision, maintenance of epithelial tissue, and
synthesis of mucous secretion, growth, reproduction and immunity.
The organ that is most readily affected is the eye
280
Vitamin B1 Deficiency (Beriberi):
Occurs when people consume highly milled polished rice or maize, and starchy roots such
as cassava, which are deprived of thiamine content
Vitamin E Deficiency
It is not common among human beings as it is widely distributed in foods.
282
Anaemia
Anaemia is a pathological condition arising as a result of low level of haemoglobin which
impairs oxygen transport to the tissues. There are various types of Anaemia such
Haemorrhagic, haemolytic and nutritional Anaemia.
Nutritional anaemia is due to deficiency of nutrients that are needed for the synthesis of
red blood cells: iron, folic acid and vitamin B12.
Thus nutritional anaemia includes: Iron deficiency anaemia, Folic acid deficiency
anaemia and Vitamin B12 deficiency anaemia.
Iodine Deficiency
Deficiency of iodine in the body leads to conditions termed iodine deficiency disorders
(IDD)
Iodine is found in the soil and is picked up by different foods (plants, animals, water)
obtainable in the area
The major cause of iodine deficiency is its loss from the soil through leaching. Iodine
deficiency manifests as goitre as well as a variety of conditions termed hypothyroidism.
283
Activity: Small Group Discussion ( 10 minutes)
ALLOW few groups to present and the rest to add points not mentioned
Vitamin A
Promotion of horticultural foods (fruits and vegetables such as carrots, cabbage and sweet
potatoes)
Promotion of production and use of red palm oil and other cooking oils
Improvement of appropriate child feeding: Breastfeeding and Improved complementary foods
Use of milk and milk products
Early treatment of diseases (measles, respiratory tract infections, diarrhea)
Promotion of immunization coverage
Vitamin A supplementation (to children, lactating women)
Fortification of foods with Vitamin A
Vitamin B1 (Thiamine)
Consumption of diet containing adequate quantities of vitamin B
If highly milled white rice is the staple food, diet should be supplemented with foods rich in
thiamine: nuts, beans, peas and other pulses, whole grain cereals and yeast based products
Nutrition education to stress cause of diseases, foods that should be consumed, and ways to
minimize vitamin loss
Vitamin B2 (Riboflavin)
Consumption of diet containing adequate quantities of vitamin B2 such as eggs, milk and
milk products, meat, fish, whole cereals, oil seeds, nuts and leafy vegetables
Vitamin B3 (Niacin)
Diversity in the diet
Production and consumption of food known to prevent pellagra i.e. those rich in niacin
such us nuts and tryptophan such as eggs, milk, lean meat and fish should be increased
Enrich milled maize meal with niacin
Niacin tablets are administered as prophylaxis in prisons, refugee camps and institutions
in areas where pellagra is endemic.
Nutrition education
Vitamin C
Increased production and consumption of vitamin C rich foods: fruits and vegetables.
Encourage the use of wild edible fruits and vegetables
Provision of vegetable fruits and fruits juices to all community members (including
children beginning at six months)
284
Nutrition education in consumption of vitamin C rich foods, minimizing vitamin C loss in
cooking and food preparation
Vitamin D
All children get adequate amount of sunlight
Children, pregnant women and lactating women should have adequate calcium and
vitamin D in their diet
Attend clinic regularly
Fish- liver oils, egg yolk, milk, butter, cheese and ghee
Establish allowing supplementation of cod-liver oil or other vitamin D supplements
Nutrition education (including child spacing)
Vitamin E
It is widely distributed in nature that it is difficulty to prepare a diet deficient in vitamin E
Human milk is enough for the infants
Cereal especially wheat germ oils are the richest source. Vegetable fats from corn, soya
bean, peanuts and coconut or cotton seeds are good sources followed by cereals, eggs and
meat and green leaves such as spinach.
Vitamin K
Bacteria in the intestine normally produce it in adequate amount
Fresh dark green vegetables especially spinach, kale and cauliflower
Plant oils, rice bran oil and wheat germ oil, soya bean and cotton seed oils are best
sources
Iodine
Various medicinal preparations are administered, such as:
o Injectable iodized oil
o Iodinated oil capsules
o Salt iodation: emphasis should be on salt iodation only because currently other strategies
are less commonly usedControl of Iodine Deficiency
Iron
Promotion of consumption of iron- and vitamin-rich foods
Prevention and treatment of anemia-related diseases (malaria, worm infestation)
Iron and folic acid supplementation to the most at risk groups (children, pregnant women,
sickle cell disease patients)
Fortification of foods with relevant nutrients (iron, folic acid)
Prevention and treatment of anaemia-related diseases (malaria, worm infestation)
References
Beaton G.H. & Bengoa J.M. (1976).Nutrition in Preventive Medicine. Geneva: WHO
King, S. F & Burgess, A. (2000). Nutrition for Developing Countries. (2nded.). New York:
Felicity Oxford University Press
286
Kumar P. & Clark, M. (2006).Clinical Medicine.(6thed.) New York: Elsevier Limited.
Tanzania Food and Nutrition Centre.(2009). National Guidelines for Nutrition Care and
Support for People Living with HIV.(2nded.) Dar es Salaam: TFNC
Wardlaw G.M. (2003). Contemporary Nutrition: Issues and Insights. (4thed.) Phidalephia: Mc
GrawHill,
287
Handout 43.1: Nutrition Supplements and Associated
Nutrient Disorders
288
Handout 43.2: Nutrition Supplements and Associated
Nutrient Disorders
289
Handout 43.3: Nutrition Supplements
290
Session 44: Specialised Food Therapy
Prerequisites
None
Learning Tasks
By the end of this session students are expected to be able to:
Define Specialised Food Therapy
Explain Nutrients Required for Different Groups
Explain Entry and Exist Criteria for Specialised Food Products
Describe Different Types of Specialised Food Products
Describe the Importance of Nutritional Therapy for Acute Malnourished Clients
Resources Needed
Flip charts, marker pens, and masking tape
Black/white board, chalk and whiteboard markers
Computer and LCD projector
Handout 44.1
SESSION OVERVIEW
Activity/
Step Time Content
Method
1 05 minutes Presentation Introduction, Learning Tasks
50 minutes Presentation
2 Common Nutritional Deficiency Diseases
Buzzing
40minutes Presentation Management of Common Nutritional
3
Group discussion Deficiency Diseases
4 05 minutes Presentation Key Points
291
SESSION CONTENTS
ASK students to pair up and buzz on the following question for 2 minutes
ALLOW few pairs to respond and let other pairs to add on points not mentioned
Malnutrition
Can occur at any time in the life cycle.
When it occurs early in life, irreversible damages can be done to the body and brain
Affects a significant proportion of populations, presenting as macro and or micronutrient
deficiency disorders.
Nutrition disorder means any kind of disorder caused by eating too little or too much of
one or more different nutrients.
Classification of Malnutrition
Can be classified in different ways but most commonly as under nutrition or over
nutrition.
o Under Nutrition occurs when nutrients intake does not meet nutrients needs.
o Many nutrients are in high demand due to the constant state of cell lose and later
regeneration in the body.
o Over nutrition is prolonged consumption of more nutrients than the body needs
Kwashiorkor
292
Caused by failure to provide an adequate dietary sources of protein to substitute for the
protein
Signs and symptoms includes:
o failure of growth but the child is not severely wasted,
o swollen abdomen,
o hair changes (hair becomes brown, straight and soft)
o skin rashes,
o child becomes inactive, apathetic, irritable and is difficult to feed,
o oedema of lower limbs
Marasmus
Causes: severe loss or chronic waste of fat, muscles and other tissues of the body. The
disease occurs due to shortage of basic nutrition, proteins, vitamins and calories to the
body. It is inadequate energy intake in all forms, including protein.
Signs and Symptoms of Marasmus: remarkable failure of growth, severe muscle wasting
with flaccid, wrinkled skin and bony prominence, the child looks awake and hungry and
displays what is referred to as ‘old person’s face and Oedema is absent
Prevention of PEM
The different strategies may include:
Incorporating nutrition objectives into development of policies and programmes
Improving household food security
Protection and promotion of good health
Improving the quality and safety of foods
Protect and promote breastfeeding and complementary feeding
Early treatment of common diseases
Immunization
Growth monitoring
Promoting appropriate diets and healthy lifestyles
Vitamin A Deficiency
It plays important roles in the body including vision, maintenance of epithelial tissue, and
synthesis of mucous secretion, growth, reproduction and immunity.
The organ that is most readily affected is the eye.
Vitamin E Deficiency
It is not common among human beings as it is widely distributed in foods.
Anaemia
295
Anaemia is a pathological condition arising as a result of low level of haemoglobin which
impairs oxygen transport to the tissues. There are various types of Anaemia such
Haemorrhagic, haemolytic and nutritional Anaemia.
Nutritional anaemia is due to deficiency of nutrients that are needed for the synthesis of
red blood cells: iron, folic acid and vitamin B12.
Thus nutritional anaemia includes: Iron deficiency anaemia, Folic acid deficiency
anaemia and Vitamin B12 deficiency anaemia.
Iodine Deficiency
Deficiency of iodine in the body leads to conditions termed iodine deficiency disorders
(IDD).
Iodine is found in the soil and is picked up by different foods (plants, animals, water)
obtainable in the area.
The major cause of iodine deficiency is its loss from the soil through leaching. Iodine
deficiency manifests as goitre as well as a variety of conditions termed hypothyroidism.
Symptoms and Signs of Iodine Deficiency Disorders:
Goitre
A person who is hypothyroid: Feels cold easily, moves slowly and lacks energy, think
slowly and appear unconcerned, may be sleepy, has a dry skin and may be constipated
A child who is hypothyroid: Also grows slowly, may be very short and may not do well
in school
296
Women who are hypothyroid during pregnancy may also have; Miscarriage or still birth,
Low birth weight babies, Babies with congenital deformities and Babies with cretinism
STEP 3: Management of Nutritional Deficiency Diseases (40 minutes)
ALLOW few groups to present and the rest to add points not mentioned
Vitamin A
Promotion of horticultural foods (fruits and vegetables such as carrots, cabbage and sweet
potatoes)
Promotion of production and use of red palm oil and other cooking oils
Improvement of appropriate child feeding: Breastfeeding and Improved complementary
foods
Use of milk and milk products
Early treatment of diseases (measles, respiratory tract infections, diarrhea)
Promotion of immunization coverage
Vitamin A supplementation (to children, lactating women)
Fortification of foods with Vitamin A
Vitamin B1 (Thiamine)
Consumption of diet containing adequate quantities of vitamin B
If highly milled white rice is the staple food, diet should be supplemented with foods rich in
thiamine: nuts, beans, peas and other pulses, whole grain cereals and yeast based products
Nutrition education to stress cause of diseases, foods that should be consumed, and ways to
minimize vitamin loss
Vitamin B2 (Riboflavin)
Consumption of diet containing adequate quantities of vitamin B2 such as eggs, milk and
milk products, meat, fish, whole cereals, oil seeds, nuts and leafy vegetables
Vitamin B3 (Niacin)
Diversity in the diet
Production and consumption of food known to prevent pellagra i.e. those rich in niacin
such us nuts and tryptophan such as eggs, milk, lean meat and fish should be increased
Enrich milled maize meal with niacin
Niacin tablets are administered as prophylaxis in prisons, refugee camps and institutions
in areas where pellagra is endemic.
297
Nutrition education
Vitamin C
Increased production and consumption of vitamin C rich foods: fruits and vegetables.
Encourage the use of wild edible fruits and vegetables
Provision of vegetable fruits and fruits juices to all community members (including
children beginning at six months)
Nutrition education in consumption of vitamin C rich foods, minimizing vitamin C loss in
cooking and food preparation
Vitamin D
All children get adequate amount of sunlight
Children, pregnant women and lactating women should have adequate calcium and
vitamin D in their diet
Attend clinic regularly
Fish- liver oils, egg yolk, milk, butter, cheese and ghee
Establish allowing supplementation of cod-liver oil or other vitamin D supplements
Nutrition education (including child spacing)
Vitamin E
It is widely distributed in nature that it is difficulty to prepare a diet deficient in vitamin E
Human milk is enough for the infants
Cereal especially wheat germ oils are the richest source. Vegetable fats from corn, soya
bean, peanuts and coconut or cotton seeds are good sources followed by cereals, eggs and
meat and green leaves such as spinach.
Vitamin K
Bacteria in the intestine normally produce it in adequate amount
Fresh dark green vegetables especially spinach, kale and cauliflower
Plant oils, rice bran oil and wheat germ oil, soya bean and cotton seed oils are best
sources
Iodine
Various medicinal preparations are administered, such as:
o Injectable iodized oil
o Iodinated oil capsules
o Salt iodation: emphasis should be on salt iodation only because currently other strategies
are less commonly usedControl of Iodine Deficiency
Iron
Promotion of consumption of iron- and vitamin-rich foods
Prevention and treatment of anemia-related diseases (malaria, worm infestation)
Iron and folic acid supplementation to the most at risk groups (children, pregnant women,
sickle cell disease patients)
Fortification of foods with relevant nutrients (iron, folic acid)
Prevention and treatment of anaemia-related diseases (malaria, worm infestation)
298
Handout 43.1: Nutrition Supplements and Associated Nutrient Disorders
References
Beaton G.H. & Bengoa J.M. (1976).Nutrition in Preventive Medicine. Geneva: WHO
King, S. F & Burgess, A. (2000). Nutrition for Developing Countries. (2nded.). New York:
Felicity Oxford University Press
Kumar P. & Clark, M. (2006).Clinical Medicine. (6thed.) New York: Elsevier Limited
299
Latham M. C (1997). Human Nutrition in the Developing World.David Lubin Memorial
Library
McLaren.S. (1992).A Colour Atlas and Text of Diet-Related Disorders. (2nded.) BPCC
Hazells Ltd, Aylesbury, England
Tanzania Food and Nutrition Centre.(2009). National Guidelines for Nutrition Care and
Support for People Living with HIV. (2nded.) Dar es Salaam: TFNC
Wardlaw G.M. (2003). Contemporary Nutrition: Issues and Insights. (4thed.) Phidalephia: Mc
GrawHill,
300
Handout 43.1: Nutrition Supplements and Associated
Nutrient Disorders
301
Handout 43.2: Nutrition Supplements and Associated
Nutrient Disorders
302
Handout 43.3: Nutrition Supplements
303
Hand Out 44.1: Specialised Food Products Used in Tanzania
a) F 75 and F 100
304
b) READY TO USE THERAPETIC FOOD ‘Plumpy'Nut.
It is a paste of groundnut composed of vegetable fat, peanut butter, skimmed milk powder,
lactoserum, maltodextrin, sugar, mineral and vitamin complex
305
c) FORTIFIED BLENDED FOOD (FBF)
High Energy Pre-cooked Porridge Flour, Fortified with Vitamins & Minerals
Maize 64.4%,
Soybeans 25%
Sugar 5%,
Palm Olein Oil 5%,
Vitamins & Minerals 0.6%
306